<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3863710/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: A genome-wide interaction study</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863710/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Endocrine-related cancer"><meta name="citation_title" content="Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: A genome-wide interaction study"><meta name="citation_authors" content="Anja Rudolph, Rebecca Hein, Sara Lindström, Lars Beckmann, Sabine Behrens, Jianjun Liu, Hugues Aschard, Manjeet K. Bolla, Jean Wang, Thérèse Truong, Emilie Cordina-Duverger, Florence Menegaux, Thomas Brüning, Volker Harth, The GENICA Network, Gianluca Severi, Laura Baglietto, Melissa Southey, Stephen J. Chanock, Jolanta Lissowska, Jonine D. Figueroa, Mikael Eriksson, Keith Humpreys, Hatef Darabi, Janet E. Olson, Kristen N. Stevens, Celine M. Vachon, Julia A. Knight, Gord Glendon, Anna Marie Mulligan, Alan Ashworth, Nicholas Orr, Minouk Schoemaker, Penny M. Webb, kConFab Investigators, AOCS Management Group, Pascal Guénel, Hiltrud Brauch, Graham Giles, Montserrat García-Closas, Kamila Czene, Georgia Chenevix-Trench, Fergus J. Couch, Irene L. Andrulis, Anthony Swerdlow, David J. Hunter, Dieter Flesch-Janys, Douglas F. Easton, Per Hall, Heli Nevanlinna, Peter Kraft, Jenny Chang-Claude"><meta name="citation_date" content="December 2013"><meta name="citation_issue" content="6"><meta name="citation_volume" content="20"><meta name="citation_firstpage" content="875"><meta name="citation_doi" content="10.1530/ERC-13-0349"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3863710/?report=abstract"><meta name="citation_pmid" content="24080446"><meta name="DC.Title" content="Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: A genome-wide interaction study"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Anja Rudolph"><meta name="DC.Contributor" content="Rebecca Hein"><meta name="DC.Contributor" content="Sara Lindström"><meta name="DC.Contributor" content="Lars Beckmann"><meta name="DC.Contributor" content="Sabine Behrens"><meta name="DC.Contributor" content="Jianjun Liu"><meta name="DC.Contributor" content="Hugues Aschard"><meta name="DC.Contributor" content="Manjeet K. Bolla"><meta name="DC.Contributor" content="Jean Wang"><meta name="DC.Contributor" content="Thérèse Truong"><meta name="DC.Contributor" content="Emilie Cordina-Duverger"><meta name="DC.Contributor" content="Florence Menegaux"><meta name="DC.Contributor" content="Thomas Brüning"><meta name="DC.Contributor" content="Volker Harth"><meta name="DC.Contributor" content="The GENICA Network"><meta name="DC.Contributor" content="Gianluca Severi"><meta name="DC.Contributor" content="Laura Baglietto"><meta name="DC.Contributor" content="Melissa Southey"><meta name="DC.Contributor" content="Stephen J. Chanock"><meta name="DC.Contributor" content="Jolanta Lissowska"><meta name="DC.Contributor" content="Jonine D. Figueroa"><meta name="DC.Contributor" content="Mikael Eriksson"><meta name="DC.Contributor" content="Keith Humpreys"><meta name="DC.Contributor" content="Hatef Darabi"><meta name="DC.Contributor" content="Janet E. Olson"><meta name="DC.Contributor" content="Kristen N. Stevens"><meta name="DC.Contributor" content="Celine M. Vachon"><meta name="DC.Contributor" content="Julia A. Knight"><meta name="DC.Contributor" content="Gord Glendon"><meta name="DC.Contributor" content="Anna Marie Mulligan"><meta name="DC.Contributor" content="Alan Ashworth"><meta name="DC.Contributor" content="Nicholas Orr"><meta name="DC.Contributor" content="Minouk Schoemaker"><meta name="DC.Contributor" content="Penny M. Webb"><meta name="DC.Contributor" content="kConFab Investigators"><meta name="DC.Contributor" content="AOCS Management Group"><meta name="DC.Contributor" content="Pascal Guénel"><meta name="DC.Contributor" content="Hiltrud Brauch"><meta name="DC.Contributor" content="Graham Giles"><meta name="DC.Contributor" content="Montserrat García-Closas"><meta name="DC.Contributor" content="Kamila Czene"><meta name="DC.Contributor" content="Georgia Chenevix-Trench"><meta name="DC.Contributor" content="Fergus J. Couch"><meta name="DC.Contributor" content="Irene L. Andrulis"><meta name="DC.Contributor" content="Anthony Swerdlow"><meta name="DC.Contributor" content="David J. Hunter"><meta name="DC.Contributor" content="Dieter Flesch-Janys"><meta name="DC.Contributor" content="Douglas F. Easton"><meta name="DC.Contributor" content="Per Hall"><meta name="DC.Contributor" content="Heli Nevanlinna"><meta name="DC.Contributor" content="Peter Kraft"><meta name="DC.Contributor" content="Jenny Chang-Claude"><meta name="DC.Date" content="2013 Dec"><meta name="DC.Identifier" content="10.1530/ERC-13-0349"><meta name="DC.Language" content="en"><meta property="og:title" content="Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: A genome-wide interaction study"><meta property="og:type" content="article"><meta property="og:description" content="Women using menopausal hormone therapy (MHT) are at increased risk to develop breast cancer (BC). To detect genetic modifiers of the association between current use of MHT and BC risk, we conducted a meta-analysis of four genome-wide case-only studies ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863710/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3863710/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3863710/pdf/nihms529599.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8BB436DD561F210000000005D6035F.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3863710%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3863710</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Endocr Relat Cancer</a></span>. Author manuscript; available in PMC 2014 Dec 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=24080446" target="pmc_ext" ref="reftype=publisher&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Endocr Relat Cancer. 2013 Dec; 20(6): 875–887. </span></a></div><span class="fm-vol-iss-date">Published online 2013 Nov 4. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1530%2FERC-13-0349" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1530/ERC-13-0349</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3863710</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS529599</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/24080446">24080446</a></div></div></div></div><h1 class="content-title">Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: A genome-wide interaction study</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Rudolph%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558610986896" co-class="co-affbox">Anja Rudolph</a>,<sup>1</sup> <a href="/pubmed/?term=Hein%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558604897488" co-class="co-affbox">Rebecca Hein</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Lindstr%26%23x000f6%3Bm%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558574464384" co-class="co-affbox">Sara Lindström</a>,<sup>3,</sup><sup>4</sup> <a href="/pubmed/?term=Beckmann%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558646842224" co-class="co-affbox">Lars Beckmann</a>,<sup>1,</sup><sup>5</sup> <a href="/pubmed/?term=Behrens%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558608791104" co-class="co-affbox">Sabine Behrens</a>,<sup>1</sup> <a href="/pubmed/?term=Liu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558608789120" co-class="co-affbox">Jianjun Liu</a>,<sup>6</sup> <a href="/pubmed/?term=Aschard%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558610590128" co-class="co-affbox">Hugues Aschard</a>,<sup>3,</sup><sup>4</sup> <a href="/pubmed/?term=Bolla%20MK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558573775136" co-class="co-affbox">Manjeet K. Bolla</a>,<sup>7</sup> <a href="/pubmed/?term=Wang%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558573773152" co-class="co-affbox">Jean Wang</a>,<sup>7</sup> <a href="/pubmed/?term=Truong%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558571644432" co-class="co-affbox">Thérèse Truong</a>,<sup>8,</sup><sup>9</sup> <a href="/pubmed/?term=Cordina-Duverger%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558567185776" co-class="co-affbox">Emilie Cordina-Duverger</a>,<sup>8,</sup><sup>9</sup> <a href="/pubmed/?term=Menegaux%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558606820496" co-class="co-affbox">Florence Menegaux</a>,<sup>8,</sup><sup>9</sup> <a href="/pubmed/?term=Br%26%23x000fc%3Bning%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558606817776" co-class="co-affbox">Thomas Brüning</a>,<sup>10</sup> <a href="/pubmed/?term=Harth%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558607139632" co-class="co-affbox">Volker Harth</a>,<sup>11</sup> The GENICA Network,<sup>10,</sup><sup>11,</sup><sup>12,</sup><sup>13,</sup><sup>14,</sup><sup>15</sup> <a href="/pubmed/?term=Severi%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558611842304" co-class="co-affbox">Gianluca Severi</a>,<sup>16,</sup><sup>17</sup> <a href="/pubmed/?term=Baglietto%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558574288896" co-class="co-affbox">Laura Baglietto</a>,<sup>16,</sup><sup>17</sup> <a href="/pubmed/?term=Southey%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558566254752" co-class="co-affbox">Melissa Southey</a>,<sup>18</sup> <a href="/pubmed/?term=Chanock%20SJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558566252768" co-class="co-affbox">Stephen J. Chanock</a>,<sup>19</sup> <a href="/pubmed/?term=Lissowska%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558566932576" co-class="co-affbox">Jolanta Lissowska</a>,<sup>20</sup> <a href="/pubmed/?term=Figueroa%20JD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558563781680" co-class="co-affbox">Jonine D. Figueroa</a>,<sup>19</sup> <a href="/pubmed/?term=Eriksson%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558563779696" co-class="co-affbox">Mikael Eriksson</a>,<sup>21</sup> <a href="/pubmed/?term=Humpreys%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558564486832" co-class="co-affbox">Keith Humpreys</a>,<sup>21</sup> <a href="/pubmed/?term=Darabi%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558564484848" co-class="co-affbox">Hatef Darabi</a>,<sup>21</sup> <a href="/pubmed/?term=Olson%20JE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558574520144" co-class="co-affbox">Janet E. Olson</a>,<sup>22</sup> <a href="/pubmed/?term=Stevens%20KN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558611534288" co-class="co-affbox">Kristen N. Stevens</a>,<sup>22</sup> <a href="/pubmed/?term=Vachon%20CM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558611532304" co-class="co-affbox">Celine M. Vachon</a>,<sup>22</sup> <a href="/pubmed/?term=Knight%20JA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558566126704" co-class="co-affbox">Julia A. Knight</a>,<sup>23,</sup><sup>24</sup> <a href="/pubmed/?term=Glendon%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558609665392" co-class="co-affbox">Gord Glendon</a>,<sup>25</sup> <a href="/pubmed/?term=Mulligan%20AM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558609663408" co-class="co-affbox">Anna Marie Mulligan</a>,<sup>26</sup> <a href="/pubmed/?term=Ashworth%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558565152064" co-class="co-affbox">Alan Ashworth</a>,<sup>27,</sup><sup>28</sup> <a href="/pubmed/?term=Orr%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558565141248" co-class="co-affbox">Nicholas Orr</a>,<sup>27,</sup><sup>28</sup> <a href="/pubmed/?term=Schoemaker%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558565138528" co-class="co-affbox">Minouk Schoemaker</a>,<sup>27,</sup><sup>28</sup> <a href="/pubmed/?term=Webb%20PM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558646741856" co-class="co-affbox">Penny M. Webb</a>,<sup>29</sup> kConFab Investigators,<sup>30</sup> AOCS Management Group,<sup>29,</sup><sup>30</sup> <a href="/pubmed/?term=Gu%26%23x000e9%3Bnel%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558608705488" co-class="co-affbox">Pascal Guénel</a>,<sup>8,</sup><sup>9</sup> <a href="/pubmed/?term=Brauch%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558573359680" co-class="co-affbox">Hiltrud Brauch</a>,<sup>15</sup> <a href="/pubmed/?term=Giles%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558573357696" co-class="co-affbox">Graham Giles</a>,<sup>16,</sup><sup>17</sup> <a href="/pubmed/?term=Garc%26%23x000ed%3Ba-Closas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558610379088" co-class="co-affbox">Montserrat García-Closas</a>,<sup>19,</sup><sup>31</sup> <a href="/pubmed/?term=Czene%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558607950240" co-class="co-affbox">Kamila Czene</a>,<sup>21</sup> <a href="/pubmed/?term=Chenevix-Trench%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558607948256" co-class="co-affbox">Georgia Chenevix-Trench</a>,<sup>29</sup> <a href="/pubmed/?term=Couch%20FJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558566504432" co-class="co-affbox">Fergus J. Couch</a>,<sup>32</sup> <a href="/pubmed/?term=Andrulis%20IL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558610663440" co-class="co-affbox">Irene L. Andrulis</a>,<sup>33,</sup><sup>34</sup> <a href="/pubmed/?term=Swerdlow%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558610660720" co-class="co-affbox">Anthony Swerdlow</a>,<sup>28,</sup><sup>35</sup> <a href="/pubmed/?term=Hunter%20DJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558607147280" co-class="co-affbox">David J. Hunter</a>,<sup>3</sup> <a href="/pubmed/?term=Flesch-Janys%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558610147216" co-class="co-affbox">Dieter Flesch-Janys</a>,<sup>36</sup> <a href="/pubmed/?term=Easton%20DF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558610145232" co-class="co-affbox">Douglas F. Easton</a>,<sup>7,</sup><sup>37</sup> <a href="/pubmed/?term=Hall%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558574176048" co-class="co-affbox">Per Hall</a>,<sup>21</sup> <a href="/pubmed/?term=Nevanlinna%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558647682688" co-class="co-affbox">Heli Nevanlinna</a>,<sup>38</sup> <a href="/pubmed/?term=Kraft%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558647680704" co-class="co-affbox">Peter Kraft</a>,<sup>3,</sup><sup>4,</sup><sup>39</sup> and  <a href="/pubmed/?term=Chang-Claude%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446" class="affpopup" co-rid="_co_idm140558565081840" co-class="co-affbox">Jenny Chang-Claude</a><sup>1,</sup><sup>*</sup>, on behalf of the Breast Cancer Association Consortium</div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140558610986896"><h3 class="no_margin">Anja Rudolph</h3><p><sup>1</sup>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany</p><div>Find articles by <a href="/pubmed/?term=Rudolph%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Anja Rudolph</a></div></div><div id="_co_idm140558604897488"><h3 class="no_margin">Rebecca Hein</h3><p><sup>1</sup>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany</p><p><sup>2</sup>PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany</p><div>Find articles by <a href="/pubmed/?term=Hein%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Rebecca Hein</a></div></div><div id="_co_idm140558574464384"><h3 class="no_margin">Sara Lindström</h3><p><sup>3</sup>Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA</p><p><sup>4</sup>Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Lindstr%26%23x000f6%3Bm%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Sara Lindström</a></div></div><div id="_co_idm140558646842224"><h3 class="no_margin">Lars Beckmann</h3><p><sup>1</sup>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany</p><p><sup>5</sup>Foundation for Quality and Efficiency in Health Care (IQWIG), Cologne, Germany</p><div>Find articles by <a href="/pubmed/?term=Beckmann%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Lars Beckmann</a></div></div><div id="_co_idm140558608791104"><h3 class="no_margin">Sabine Behrens</h3><p><sup>1</sup>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany</p><div>Find articles by <a href="/pubmed/?term=Behrens%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Sabine Behrens</a></div></div><div id="_co_idm140558608789120"><h3 class="no_margin">Jianjun Liu</h3><p><sup>6</sup>Human Genetics, Genome Institute of Singapore, Singapore, Singapore</p><div>Find articles by <a href="/pubmed/?term=Liu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Jianjun Liu</a></div></div><div id="_co_idm140558610590128"><h3 class="no_margin">Hugues Aschard</h3><p><sup>3</sup>Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA</p><p><sup>4</sup>Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Aschard%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Hugues Aschard</a></div></div><div id="_co_idm140558573775136"><h3 class="no_margin">Manjeet K. Bolla</h3><p><sup>7</sup>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK</p><div>Find articles by <a href="/pubmed/?term=Bolla%20MK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Manjeet K. Bolla</a></div></div><div id="_co_idm140558573773152"><h3 class="no_margin">Jean Wang</h3><p><sup>7</sup>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK</p><div>Find articles by <a href="/pubmed/?term=Wang%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Jean Wang</a></div></div><div id="_co_idm140558571644432"><h3 class="no_margin">Thérèse Truong</h3><p><sup>8</sup>INSERM (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France</p><p><sup>9</sup>Unité Mixte de Recherche Scientifique (UMRS) 1018, University Paris-Sud, Villejuif, France</p><div>Find articles by <a href="/pubmed/?term=Truong%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Thérèse Truong</a></div></div><div id="_co_idm140558567185776"><h3 class="no_margin">Emilie Cordina-Duverger</h3><p><sup>8</sup>INSERM (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France</p><p><sup>9</sup>Unité Mixte de Recherche Scientifique (UMRS) 1018, University Paris-Sud, Villejuif, France</p><div>Find articles by <a href="/pubmed/?term=Cordina-Duverger%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Emilie Cordina-Duverger</a></div></div><div id="_co_idm140558606820496"><h3 class="no_margin">Florence Menegaux</h3><p><sup>8</sup>INSERM (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France</p><p><sup>9</sup>Unité Mixte de Recherche Scientifique (UMRS) 1018, University Paris-Sud, Villejuif, France</p><div>Find articles by <a href="/pubmed/?term=Menegaux%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Florence Menegaux</a></div></div><div id="_co_idm140558606817776"><h3 class="no_margin">Thomas Brüning</h3><p><sup>10</sup>Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany</p><div>Find articles by <a href="/pubmed/?term=Br%26%23x000fc%3Bning%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Thomas Brüning</a></div></div><div id="_co_idm140558607139632"><h3 class="no_margin">Volker Harth</h3><p><sup>11</sup>Institute for Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Germany</p><div>Find articles by <a href="/pubmed/?term=Harth%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Volker Harth</a></div></div><div id="_co_idm140558566850144"><h3 class="no_margin">The GENICA Network</h3><p><sup>10</sup>Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany</p><p><sup>11</sup>Institute for Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Germany</p><p><sup>12</sup>Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany</p><p><sup>13</sup>Institute of Pathology, University of Bonn, Germany</p><p><sup>14</sup>Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany</p><p><sup>15</sup>Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, Stuttgart, Germany</p><div>Find articles by <a href="/pubmed/?term=%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">The GENICA Network</a></div></div><div id="_co_idm140558611842304"><h3 class="no_margin">Gianluca Severi</h3><p><sup>16</sup>Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia</p><p><sup>17</sup>Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia</p><div>Find articles by <a href="/pubmed/?term=Severi%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Gianluca Severi</a></div></div><div id="_co_idm140558574288896"><h3 class="no_margin">Laura Baglietto</h3><p><sup>16</sup>Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia</p><p><sup>17</sup>Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia</p><div>Find articles by <a href="/pubmed/?term=Baglietto%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Laura Baglietto</a></div></div><div id="_co_idm140558566254752"><h3 class="no_margin">Melissa Southey</h3><p><sup>18</sup>Department of Pathology, The University of Melbourne, Australia</p><div>Find articles by <a href="/pubmed/?term=Southey%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Melissa Southey</a></div></div><div id="_co_idm140558566252768"><h3 class="no_margin">Stephen J. Chanock</h3><p><sup>19</sup>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America</p><div>Find articles by <a href="/pubmed/?term=Chanock%20SJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Stephen J. Chanock</a></div></div><div id="_co_idm140558566932576"><h3 class="no_margin">Jolanta Lissowska</h3><p><sup>20</sup>Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center &amp; Institute of Oncology, Warsaw, Poland</p><div>Find articles by <a href="/pubmed/?term=Lissowska%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Jolanta Lissowska</a></div></div><div id="_co_idm140558563781680"><h3 class="no_margin">Jonine D. Figueroa</h3><p><sup>19</sup>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America</p><div>Find articles by <a href="/pubmed/?term=Figueroa%20JD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Jonine D. Figueroa</a></div></div><div id="_co_idm140558563779696"><h3 class="no_margin">Mikael Eriksson</h3><p><sup>21</sup>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Eriksson%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Mikael Eriksson</a></div></div><div id="_co_idm140558564486832"><h3 class="no_margin">Keith Humpreys</h3><p><sup>21</sup>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Humpreys%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Keith Humpreys</a></div></div><div id="_co_idm140558564484848"><h3 class="no_margin">Hatef Darabi</h3><p><sup>21</sup>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Darabi%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Hatef Darabi</a></div></div><div id="_co_idm140558574520144"><h3 class="no_margin">Janet E. Olson</h3><p><sup>22</sup>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America</p><div>Find articles by <a href="/pubmed/?term=Olson%20JE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Janet E. Olson</a></div></div><div id="_co_idm140558611534288"><h3 class="no_margin">Kristen N. Stevens</h3><p><sup>22</sup>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America</p><div>Find articles by <a href="/pubmed/?term=Stevens%20KN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Kristen N. Stevens</a></div></div><div id="_co_idm140558611532304"><h3 class="no_margin">Celine M. Vachon</h3><p><sup>22</sup>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America</p><div>Find articles by <a href="/pubmed/?term=Vachon%20CM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Celine M. Vachon</a></div></div><div id="_co_idm140558566126704"><h3 class="no_margin">Julia A. Knight</h3><p><sup>23</sup>Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada</p><p><sup>24</sup>Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada</p><div>Find articles by <a href="/pubmed/?term=Knight%20JA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Julia A. Knight</a></div></div><div id="_co_idm140558609665392"><h3 class="no_margin">Gord Glendon</h3><p><sup>25</sup>Ontario Cancer Genetics Network, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada</p><div>Find articles by <a href="/pubmed/?term=Glendon%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Gord Glendon</a></div></div><div id="_co_idm140558609663408"><h3 class="no_margin">Anna Marie Mulligan</h3><p><sup>26</sup>Laboratory Medicine Program, University Health Network; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada</p><div>Find articles by <a href="/pubmed/?term=Mulligan%20AM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Anna Marie Mulligan</a></div></div><div id="_co_idm140558565152064"><h3 class="no_margin">Alan Ashworth</h3><p><sup>27</sup>Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK</p><p><sup>28</sup>Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, UK</p><div>Find articles by <a href="/pubmed/?term=Ashworth%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Alan Ashworth</a></div></div><div id="_co_idm140558565141248"><h3 class="no_margin">Nicholas Orr</h3><p><sup>27</sup>Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK</p><p><sup>28</sup>Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, UK</p><div>Find articles by <a href="/pubmed/?term=Orr%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Nicholas Orr</a></div></div><div id="_co_idm140558565138528"><h3 class="no_margin">Minouk Schoemaker</h3><p><sup>27</sup>Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK</p><p><sup>28</sup>Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, UK</p><div>Find articles by <a href="/pubmed/?term=Schoemaker%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Minouk Schoemaker</a></div></div><div id="_co_idm140558646741856"><h3 class="no_margin">Penny M. Webb</h3><p><sup>29</sup>Queensland Institute of Medical Research, Brisbane, Australia</p><div>Find articles by <a href="/pubmed/?term=Webb%20PM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Penny M. Webb</a></div></div><div id="_co_idm140558574415696"><h3 class="no_margin">kConFab Investigators</h3><p><sup>30</sup>Peter MacCallum Cancer Center, Melbourne, Australia</p><div>Find articles by <a href="/pubmed/?term=%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">kConFab Investigators</a></div></div><div id="_co_idm140558574414336"><h3 class="no_margin">AOCS Management Group</h3><p><sup>29</sup>Queensland Institute of Medical Research, Brisbane, Australia</p><p><sup>30</sup>Peter MacCallum Cancer Center, Melbourne, Australia</p><div>Find articles by <a href="/pubmed/?term=%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">AOCS Management Group</a></div></div><div id="_co_idm140558608705488"><h3 class="no_margin">Pascal Guénel</h3><p><sup>8</sup>INSERM (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France</p><p><sup>9</sup>Unité Mixte de Recherche Scientifique (UMRS) 1018, University Paris-Sud, Villejuif, France</p><div>Find articles by <a href="/pubmed/?term=Gu%26%23x000e9%3Bnel%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Pascal Guénel</a></div></div><div id="_co_idm140558573359680"><h3 class="no_margin">Hiltrud Brauch</h3><p><sup>15</sup>Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, Stuttgart, Germany</p><div>Find articles by <a href="/pubmed/?term=Brauch%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Hiltrud Brauch</a></div></div><div id="_co_idm140558573357696"><h3 class="no_margin">Graham Giles</h3><p><sup>16</sup>Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia</p><p><sup>17</sup>Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia</p><div>Find articles by <a href="/pubmed/?term=Giles%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Graham Giles</a></div></div><div id="_co_idm140558610379088"><h3 class="no_margin">Montserrat García-Closas</h3><p><sup>19</sup>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America</p><p><sup>31</sup>Sections of Epidemiology and Genetics, Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom</p><div>Find articles by <a href="/pubmed/?term=Garc%26%23x000ed%3Ba-Closas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Montserrat García-Closas</a></div></div><div id="_co_idm140558607950240"><h3 class="no_margin">Kamila Czene</h3><p><sup>21</sup>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Czene%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Kamila Czene</a></div></div><div id="_co_idm140558607948256"><h3 class="no_margin">Georgia Chenevix-Trench</h3><p><sup>29</sup>Queensland Institute of Medical Research, Brisbane, Australia</p><div>Find articles by <a href="/pubmed/?term=Chenevix-Trench%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Georgia Chenevix-Trench</a></div></div><div id="_co_idm140558566504432"><h3 class="no_margin">Fergus J. Couch</h3><p><sup>32</sup>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America</p><div>Find articles by <a href="/pubmed/?term=Couch%20FJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Fergus J. Couch</a></div></div><div id="_co_idm140558610663440"><h3 class="no_margin">Irene L. Andrulis</h3><p><sup>33</sup>Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada</p><p><sup>34</sup>Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada</p><div>Find articles by <a href="/pubmed/?term=Andrulis%20IL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Irene L. Andrulis</a></div></div><div id="_co_idm140558610660720"><h3 class="no_margin">Anthony Swerdlow</h3><p><sup>28</sup>Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, UK</p><p><sup>35</sup>Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey, UK</p><div>Find articles by <a href="/pubmed/?term=Swerdlow%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Anthony Swerdlow</a></div></div><div id="_co_idm140558607147280"><h3 class="no_margin">David J. Hunter</h3><p><sup>3</sup>Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Hunter%20DJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">David J. Hunter</a></div></div><div id="_co_idm140558610147216"><h3 class="no_margin">Dieter Flesch-Janys</h3><p><sup>36</sup>Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany</p><div>Find articles by <a href="/pubmed/?term=Flesch-Janys%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Dieter Flesch-Janys</a></div></div><div id="_co_idm140558610145232"><h3 class="no_margin">Douglas F. Easton</h3><p><sup>7</sup>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK</p><p><sup>37</sup>Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK</p><div>Find articles by <a href="/pubmed/?term=Easton%20DF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Douglas F. Easton</a></div></div><div id="_co_idm140558574176048"><h3 class="no_margin">Per Hall</h3><p><sup>21</sup>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Hall%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Per Hall</a></div></div><div id="_co_idm140558647682688"><h3 class="no_margin">Heli Nevanlinna</h3><p><sup>38</sup>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland</p><div>Find articles by <a href="/pubmed/?term=Nevanlinna%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Heli Nevanlinna</a></div></div><div id="_co_idm140558647680704"><h3 class="no_margin">Peter Kraft</h3><p><sup>3</sup>Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA</p><p><sup>4</sup>Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA</p><p><sup>39</sup>Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Kraft%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Peter Kraft</a></div></div><div id="_co_idm140558565081840"><h3 class="no_margin">Jenny Chang-Claude</h3><p><sup>1</sup>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany</p><div>Find articles by <a href="/pubmed/?term=Chang-Claude%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24080446">Jenny Chang-Claude</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140558570739808_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140558570739808_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140558570739808_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Foundation for Quality and Efficiency in Health Care (IQWIG), Cologne, Germany</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Human Genetics, Genome Institute of Singapore, Singapore, Singapore</div><div class="fm-affl" id="A7" lang="en"><sup>7</sup>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK</div><div class="fm-affl" id="A8" lang="en"><sup>8</sup>INSERM (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France</div><div class="fm-affl" id="A9" lang="en"><sup>9</sup>Unité Mixte de Recherche Scientifique (UMRS) 1018, University Paris-Sud, Villejuif, France</div><div class="fm-affl" id="A10" lang="en"><sup>10</sup>Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany</div><div class="fm-affl" id="A11" lang="en"><sup>11</sup>Institute for Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Germany</div><div class="fm-affl" id="A12" lang="en"><sup>12</sup>Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany</div><div class="fm-affl" id="A13" lang="en"><sup>13</sup>Institute of Pathology, University of Bonn, Germany</div><div class="fm-affl" id="A14" lang="en"><sup>14</sup>Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany</div><div class="fm-affl" id="A15" lang="en"><sup>15</sup>Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, Stuttgart, Germany</div><div class="fm-affl" id="A16" lang="en"><sup>16</sup>Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia</div><div class="fm-affl" id="A17" lang="en"><sup>17</sup>Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia</div><div class="fm-affl" id="A18" lang="en"><sup>18</sup>Department of Pathology, The University of Melbourne, Australia</div><div class="fm-affl" id="A19" lang="en"><sup>19</sup>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America</div><div class="fm-affl" id="A20" lang="en"><sup>20</sup>Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center &amp; Institute of Oncology, Warsaw, Poland</div><div class="fm-affl" id="A21" lang="en"><sup>21</sup>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden</div><div class="fm-affl" id="A22" lang="en"><sup>22</sup>Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America</div><div class="fm-affl" id="A23" lang="en"><sup>23</sup>Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada</div><div class="fm-affl" id="A24" lang="en"><sup>24</sup>Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada</div><div class="fm-affl" id="A25" lang="en"><sup>25</sup>Ontario Cancer Genetics Network, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada</div><div class="fm-affl" id="A26" lang="en"><sup>26</sup>Laboratory Medicine Program, University Health Network; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada</div><div class="fm-affl" id="A27" lang="en"><sup>27</sup>Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK</div><div class="fm-affl" id="A28" lang="en"><sup>28</sup>Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, UK</div><div class="fm-affl" id="A29" lang="en"><sup>29</sup>Queensland Institute of Medical Research, Brisbane, Australia</div><div class="fm-affl" id="A30" lang="en"><sup>30</sup>Peter MacCallum Cancer Center, Melbourne, Australia</div><div class="fm-affl" id="A31" lang="en"><sup>31</sup>Sections of Epidemiology and Genetics, Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom</div><div class="fm-affl" id="A32" lang="en"><sup>32</sup>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America</div><div class="fm-affl" id="A33" lang="en"><sup>33</sup>Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada</div><div class="fm-affl" id="A34" lang="en"><sup>34</sup>Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada</div><div class="fm-affl" id="A35" lang="en"><sup>35</sup>Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey, UK</div><div class="fm-affl" id="A36" lang="en"><sup>36</sup>Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany</div><div class="fm-affl" id="A37" lang="en"><sup>37</sup>Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK</div><div class="fm-affl" id="A38" lang="en"><sup>38</sup>Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland</div><div class="fm-affl" id="A39" lang="en"><sup>39</sup>Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA</div><div id="FN1"><sup>*</sup>Corresponding author: Jenny Chang-Claude, Division of Cancer Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 581, D-69120 Heidelberg, Germany, Phone: 49-6221-422373, Fax: 49-6221-422203, <a href="mailto:dev@null" data-email="ed.zfkd@edualc-gnahc.j" class="oemail">ed.zfkd@edualc-gnahc.j</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140558570739808_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=24080446" target="pmc_ext" ref="reftype=publisher&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Endocr Relat Cancer</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3863710/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="12" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-1.doc" data-ga-action="click_feat_suppl">NIHMS529599-supplement-1.doc</a><span style="color:gray"> (63K)</span></div><div class="small guid">GUID:&nbsp;EF97CE19-B0EB-490E-8A75-51A116D2C0B1</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>10.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-10.doc" data-ga-action="click_feat_suppl">NIHMS529599-supplement-10.doc</a><span style="color:gray"> (68K)</span></div><div class="small guid">GUID:&nbsp;880EC6BD-8F02-415E-BC98-E22FA4D99B91</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>11.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-11.doc" data-ga-action="click_feat_suppl">NIHMS529599-supplement-11.doc</a><span style="color:gray"> (54K)</span></div><div class="small guid">GUID:&nbsp;FC90B13E-DA66-4C8E-A9A6-601FB42EB400</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>12.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-12.doc" data-ga-action="click_feat_suppl">NIHMS529599-supplement-12.doc</a><span style="color:gray"> (56K)</span></div><div class="small guid">GUID:&nbsp;1ED1FCD2-1566-4C88-991A-C02C6F400A60</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>2.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-2.doc" data-ga-action="click_feat_suppl">NIHMS529599-supplement-2.doc</a><span style="color:gray"> (60K)</span></div><div class="small guid">GUID:&nbsp;9690FCDD-75B9-45B5-AE60-5B0FD7938469</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>3.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-3.doc" data-ga-action="click_feat_suppl">NIHMS529599-supplement-3.doc</a><span style="color:gray"> (465K)</span></div><div class="small guid">GUID:&nbsp;74C8BC35-00F8-45A3-805B-FC894E22E057</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>4.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-4.doc" data-ga-action="click_feat_suppl">NIHMS529599-supplement-4.doc</a><span style="color:gray"> (46K)</span></div><div class="small guid">GUID:&nbsp;5899DAF5-26F9-4A50-BC67-50D911CD2DD5</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>5.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-5.pdf" data-ga-action="click_feat_suppl">NIHMS529599-supplement-5.pdf</a><span style="color:gray"> (46K)</span></div><div class="small guid">GUID:&nbsp;E753EBC8-12AD-493D-9A65-F6CED4A4ADEF</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>6.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-6.pdf" data-ga-action="click_feat_suppl">NIHMS529599-supplement-6.pdf</a><span style="color:gray"> (211K)</span></div><div class="small guid">GUID:&nbsp;AF1D5D7D-F1E6-4863-B699-0CCDE2D0C9C2</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>7.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-7.pdf" data-ga-action="click_feat_suppl">NIHMS529599-supplement-7.pdf</a><span style="color:gray"> (180K)</span></div><div class="small guid">GUID:&nbsp;A700A95A-EA0F-4404-9E9D-841DAFEFE5C2</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>8.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-8.doc" data-ga-action="click_feat_suppl">NIHMS529599-supplement-8.doc</a><span style="color:gray"> (60K)</span></div><div class="small guid">GUID:&nbsp;04CCAEE0-ADB6-4493-9005-BFF11A8D4AAD</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>9.</strong></div><div><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-9.doc" data-ga-action="click_feat_suppl">NIHMS529599-supplement-9.doc</a><span style="color:gray"> (41K)</span></div><div class="small guid">GUID:&nbsp;4CD5727E-D583-4B3F-8302-599FC2ABD0B2</div></div></dd></dl></div><div id="idm140558573188192" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140558573188192title">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">Women using menopausal hormone therapy (MHT) are at increased risk to develop breast cancer (BC). To detect genetic modifiers of the association between current use of MHT and BC risk, we conducted a meta-analysis of four genome-wide case-only studies followed by replication in eleven case-control studies. We used a case-only design to assess interactions between single nucleotide polymorphisms (SNPs) and current MHT use on risk of overall and lobular BC. The discovery stage included 2,920 cases (541 lobular) from four genome-wide association studies. The top 1,391 SNPs showing <em>P</em>-values for interaction (<em>P</em><sub>int</sub>) &lt;3.0×10<sup>−03</sup> were selected for replication using pooled case-control data from eleven studies of the Breast Cancer Association Consortium, including 7,689 cases (676 lobular) and 9,266 controls. Fixed effects meta-analysis was used to derive combined <em>P</em><sub>int</sub>. No SNP reached genome-wide significance in either the discovery or combined stage. We observed effect modification of current MHT use on overall BC risk by two SNPs on chr13 near <em>POMP</em> (combined <em>P</em><sub>int</sub>≤8.9×10<sup>−06</sup>), two SNPs in <em>SLC25A21</em> (combined <em>P</em><sub>int</sub>≤4.8×10<sup>−05</sup>), and three SNPs in <em>PLCG2</em> (combined <em>P</em><sub>int</sub>≤4.5×10<sup>−05</sup>). The association between lobular BC risk was potentially modified by one SNP in TMEFF2 (combined <em>P</em><sub>int</sub>≤2.7×10<sup>−05</sup>), one SNP in <em>CD80</em> (combined <em>P</em><sub>int</sub>≤8.2×10<sup>−06</sup>), three SNPs on chr17 near <em>TMEM132E</em> (combined <em>P</em><sub>int</sub>≤2.2×10<sup>−06</sup>), and two SNPs on chr18 near <em>SLC25A52</em> (combined <em>P</em><sub>int</sub>≤4.6×10<sup>−05</sup>). In conclusion, polymorphisms in genes related to solute transportation in mitochondria, transmembrane signaling and immune cell activation are potentially modifying BC risk associated with current use of MHT. These findings warrant replication in independent studies.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">breast cancer, genetic variation, menopausal hormone therapy, genome-wide</span></div></div><div id="S1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">INTRODUCTION</h2><p id="P2" class="p p-first">Menopausal hormone therapy (MHT) is prescribed to women in order to alleviate climacteric symptoms and it is still commonly used despite evidence of associations with increased risk for cardiovascular diseases and breast cancer (<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047473">Farquhar <em>et al.</em> 2009</a>; <a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047506">Sprague <em>et al.</em> 2012</a>; <a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047492">Tsai <em>et al.</em> 2011</a>). Regarding breast cancer, only recent use of MHT increases risk and the elevated risk dissipates within two years after cessation of use (<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047523">Narod 2011</a>). Furthermore, the associated risk varies by type of MHT preparation and is greater for use of combined estrogen-progestogen therapy than for use of estrogen-monotherapy (<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047505">Chlebowski and Anderson 2012</a>; <a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047511">Narod 2011</a>). A meta-analysis conducted in 2005 reported an odds ratio (OR) of 1.39 (95% confidence interval (CI) 1.12–1.72) for the association between use of combined estrogen-progestogen therapy and breast cancer risk, whereas the respective OR for use of estrogen-monotherapy was 1.16 (95% CI 1.06–1.28) (<a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047487">Shah <em>et al.</em> 2005</a>). Also, differences by histology have been observed, with a stronger increase in risk for lobular and tubular breast cancer compared with ductal breast cancer (<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047486">Bakken <em>et al.</em> 2011</a>; <a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047477">Flesch-Janys <em>et al.</em> 2008</a>).</p><p id="P3">Understanding of the role of female sex hormones in breast carcinogenesis has already led to the development of therapeutic strategies such as the adjuvant endocrine therapy for estrogen receptor positive breast cancer (<a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047519">Smith and Dowsett 2003</a>). By investigating genetic modifiers of MHT associated breast cancer, the underlying mechanisms could be further elucidated. The detection of genes involved in hormone-related breast carcinogenesis could lead to new strategies for breast cancer prevention and treatment. Knowledge of genetic modifiers could also contribute to safer use of MHT as the individual risk to develop breast cancer when using MHT may vary depending on the genetic background.</p><p id="P4">Previous studies investigating interactions between single nucleotide polymorphisms (SNPs) and use MHT regarding breast cancer risk predominantly pursued a candidate gene approach. Most of the reported interactions have not been followed up in further studies (<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047476">Hein <em>et al.</em> 2012</a>; <a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047499">Justenhoven <em>et al.</em> 2012</a>; <a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047501">Lee <em>et al.</em> 2011</a>). The possible interaction with variants of the known genetic susceptibility loci for breast cancer in <em>FGFR2</em> has not been clearly confirmed in subsequent studies (<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047481">Campa <em>et al.</em> 2011</a>; <a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047515">Kawase <em>et al.</em> 2009</a>; <a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047532">Nickels <em>et al.</em> 2013</a>; <a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047478">Prentice <em>et al.</em> 2009</a>; <a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047510">Rebbeck <em>et al.</em> 2009</a>; <a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047497">Travis <em>et al.</em> 2010</a>). We previously failed to replicate the most significant interaction with MHT use observed for 2q36.3 in a genome-wide interaction study using case-only design (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047504">Hein <em>et al.</em> 2013</a>).</p><p id="P5" class="p p-last">We here expand our previous work (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047474">Hein <em>et al.</em> 2013</a>) and conducted a meta-analysis of four case-only genome-wide gene-environment interaction studies for overall as well as for lobular breast cancer risk. We then evaluated the top 1,391 SNPs by case-control analyses utilizing data from eleven studies participating in the Breast Cancer Association Consortium (BCAC; <a href="http://ccge.medschl.cam.ac.uk/consortia/bcac/index.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://ccge.medschl.cam.ac.uk/consortia/bcac/index.html</a>).</p></div><div id="S2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S2title">MATERIALS AND METHODS</h2><p id="P6" class="p p-first">An overview of the included studies at each stage with respective numbers of cases and controls as well as the number of SNPs analyzed is displayed in <a href="/pmc/articles/PMC3863710/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>. All studies were approved by the relevant ethics committees and all participants gave informed consent.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3863710/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140558564185248" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms529599f1.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms529599f1.jpg" src="/pmc/articles/PMC3863710/bin/nihms529599f1.jpg"></div></a><div id="largeobj_idm140558564185248" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC3863710/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a target="object" href="/pmc/articles/PMC3863710/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3863710/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p18">Diagram describing numbers of participants, investigated SNPs and conducted analyses at each stage</p></div></div></div><div id="S3" class="sec"><h3 id="S3title">Study population of case-only genome-wide studies</h3><p id="P7" class="p p-first">Under the assumption that the genetic and environmental factors are not associated in the population from which the cases were drawn, case-only studies provide a powerful and efficient way to detect gene-environment interactions (<a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047529">Piegorsch <em>et al.</em> 1994</a>). We conducted meta-analysis of four studies with quality control checked genome-wide data and information on current MHT use: the Mammary Carcinoma Risk Factor Investigation (MARIE) from Germany (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047514">Flesch-Janys <em>et al.</em> 2008</a>), the Singapore and Sweden Breast Cancer Study (SASBAC) (<a href="#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047520">Wedren <em>et al.</em> 2004</a>), the Helsinki Breast Cancer Study (HEBCS) (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047494">Kilpivaara <em>et al.</em> 2004</a>) and the Nurses’ Health Study (NHS) from the US (<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047517">Hunter <em>et al.</em> 2007</a>). Details on all studies participating in the discovery as well as replication stage can be found in <a href="#SD8" rid="SD8" class=" supplementary-material">Supplementary Table 1</a>. In total these studies contributed 2,920 cases (541 cases with lobular tumors) to the meta-analysis.</p><p id="P8" class="p p-last">Briefly, the MARIE study is a population-based case-control study of postmenopausal women aged 50–74 years carried out in two regions in Germany with incident cases diagnosed 2001–2005 and controls matched by birth year and study region (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047531">Flesch-Janys <em>et al.</em> 2008</a>). Initially, 800 MARIE cases with known age at menopause were randomly selected for genotyping, with lobular cases oversampled (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047512">Hein <em>et al.</em> 2013</a>). After quality control checks, a total of 742 MARIE cases were included in the case-only genome-wide association analysis, of which 279 were lobular cases. SASBAC is a subset of a Swedish nationwide population-based case-control study (<a href="#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047480">Wedren <em>et al.</em> 2004</a>). The cases were incident breast cancer cases diagnosed 1993–1995 identified via the six regional cancer registries in Sweden, to which reporting is mandatory. Overall, 773 cases (36 lobular tumors) were included in the case-only genome-wide analyses (<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047500">Li <em>et al.</em> 2011</a>). A further 344 postmenopausal cases (88 lobular) were contributed by the hospital-based Finnish study HEBCS. In HEBCS, cases included both unselected breast cancer and familial breast cancer patients recruited at the Helsinki University Central Hospital, 1997–2004 (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047493">Kilpivaara <em>et al.</em> 2004</a>). The NHS cohort was established in 1976 and comprised 121,700 female registered nurses. In 1989–1990, 32,826 participants donated a blood sample. Of this sub-cohort 1,061 participants of European descent with incident postmenopausal invasive breast cancer (138 lobular) were included in the case-only genome-wide association analysis (<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047490">Hunter <em>et al.</em> 2007</a>). All subjects were of European ancestry.</p></div><div id="S4" class="sec"><h3 id="S4title">Study populations used in the replication stage</h3><p id="P9" class="p p-first-last">SNPs selected from the case-only genome-wide association studies for replication were evaluated using seven population-based studies (five case-control studies (CECILE, GENICA, MARIE, PBCS, SASBAC), one case-cohort (MCCS), and one nested case-control study (UKBGS)), and four non-population-based studies (MCBCS, kConFab/AOCS, OFBCR, pKARMA), including in total 7,689 cases (676 lobular) and 9,266 controls participating in the Breast Cancer Association Consortium (BCAC). Studies from BCAC were included if participants were of European descent and if genotype information, information on MHT use and information on reference age was available for at least 200 postmenopausal cases and 200 postmenopausal controls. A reference age of ≥54 years was used as surrogate for defining postmenopausal status if study derived information on menopausal status was missing. Participants of SASBAC and MARIE were excluded if they contributed already to the respective case-only genome-wide association studies. Additionally, cases in MCCS and pKARMA with prevalent breast cancer at time of enrollment were excluded. The reference date for controls was date of enrollment (MCCS) or date of interview (case-control studies). The reference date for cases was the date of breast cancer diagnosis. The reference age was accordingly the age at reference date. In total, 7,698 cases (676 lobular) and 9,266 controls contributed to the replication analysis.</p></div><div id="S5" class="sec"><h3 id="S5title">Menopausal hormone therapy exposure definition</h3><p id="P10" class="p p-first-last">Any type of MHT was taken into account when defining ever use of MHT. Only women using MHT more than three months were considered to be ever users. We defined current use of MHT as use within the last six months before reference date. Harmonization and plausibility checks of MHT information were conducted centrally for all studies participating in BCAC (<a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047527">Nickels <em>et al.</em> 2013</a>).</p></div><div id="S6" class="sec"><h3 id="S6title">Genotyping and Quality control</h3><p id="P11" class="p p-first">Genotyping was performed using the Illumina Humancnv370-duo chip (318,237 SNPs) in the MARIE study and the Illumina HumanHap550 chip I in SASBAC (500,007 SNPs), HEBCS (510,067 SNPs), and NHS (540,000 SNPs). Genotyping in NHS was part of the Cancer Genetic Markers of Susceptibility (CGEMS) project. All studies provided quality control checked genotype data.</p><p id="P12" class="p p-last">SNPs selected for replication were genotyped on a custom Illumina iSelect genotyping array (iCOGS) that was designed by BCAC in collaboration with three other consortia (the Collaborative Oncological Gene-environment Study, COGS) (<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047488">Michailidou <em>et al.</em> 2013</a>). After genotyping the iCOGS data was centrally quality controlled, which lead to an exclusion of 56 SNPs selected for replication. We additionally excluded 9 SNPs with MAF &lt; 0.05 in the replication dataset.</p></div><div id="S7" class="sec"><h3 id="S7title">Imputation</h3><p id="P13" class="p p-first-last">All SNPs genotyped in the genome-wide studies, which were also contained in the HapMap phase II release 24 data, were used for imputation of additional genotypes using the software MACH 1.0.16 (<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047489">Li <em>et al.</em> 2010</a>). Employing the ‘autoflip’ option, the alleles are coded according to a unique reference scheme, so that the same allele was coded as reference in all four genome-wide case-only studies. For quality control of imputed data, imputed SNPs with minor allele frequency (MAF) &lt;0.01 or r<sup>2</sup> &lt;0.3 were excluded from the analysis.</p></div><div id="S8" class="sec"><h3 id="S8title">SNP selection for replication</h3><p id="P14" class="p p-first-last">A list of 1,391 SNPs was generated based on the lowest <em>P</em><sub>int</sub> (cut-off <em>P</em><sub>int</sub> &lt;3.0×10<sup>−03</sup>) derived from the analysis of multiplicative interaction between MHT and breast cancer risk, after merging the results for overall and lobular breast cancer. A total of 3,277 SNPs were selected based on the interaction with overall breast cancer and 1,723 selected based on their association with lobular breast cancer. These SNPs were filtered according to the criteria MAF ≥0.05, <em>P-</em>value ≥0.05 for Cochran’s Q or I<sup>2</sup> &lt;30% and the availability of the respective SNP data in at least two case-only studies.</p></div><div id="S9" class="sec sec-last"><h3 id="S9title">Statistical Analysis</h3><p id="P15" class="p p-first">We tested for multiplicative SNPxMHT interactions on the genome-wide level (2.5 million SNPs) in case-only analysis using logistic regression with MHT use (current use codes as 1, never/past use coded as 0) as the outcome variable and the SNP as the explanatory variable. The SNP was assessed according to a log-additive genetic model, i.e. a 1 df test for trend by number of minor alleles (0, 1, or 2). Uncertainty of imputed SNPs was accounted for by using estimated genotype probabilities for imputed SNPs in the regression model. Covariates were not considered in the case-only analyses. These analyses were performed with the software ProbABEL version 0.1–2-plus (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047516">Aulchenko <em>et al.</em> 2010</a>). Only genotyped SNPs that were also contained in the HapMap reference data and imputed SNPs were included in case-only analyses. Analyses were performed for all cases as well as separately for lobular cases. Since only individuals of European descent were included, the genomic inflation factor lambda was close to one (HEBCS λ = 1.016; MARIE λ = 1.014; SASBAC λ = 1.009) and, in case of NHS, there was also no indication for population stratification (<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047479">Hunter <em>et al.</em> 2007</a>). Therefore, the analyses were not corrected for population stratification. Combined results based on the four case-only analyses were obtained from a meta-analysis assuming a fixed effects model, using the software PLINK, version 1.07 (<a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047496">Purcell <em>et al.</em> 2007</a>). Heterogeneity between studies was assessed using Cochran’s Q statistic and I<sup>2</sup> (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047530">Higgins and Thompson 2002</a>).</p><p id="P16">For the replication analysis, data from eleven studies were pooled and analyzed using case-control logistic regression. These analyses were performed using SAS software, version 9.2. SNPxMHT interactions were evaluated by means of a log-likelihood ratio test, comparing models with and without a multiplicative interaction term between SNP (coded according to log-additive mode of inheritance) and current use of MHT. The models were adjusted for study, reference age, former use of MHT, and six principal components to account for population stratification. The models included also interaction terms between study design (non-population-based vs. population based) and current use of MHT as well as former use of MHT. These interaction terms were included to account for possible differences in the estimates of the MHT effect according to study design.</p><p id="P17">Results from the case-only meta-analysis and the replication were combined in a meta-analysis assuming a fixed effects model, using the package “meta”, version 2.1-2 (<a href="#R37" rid="R37" class=" bibr popnode">Schwarzer 2012</a>) within the R software, version 2.15.0 (Team 2012). Linkage disequilibrium (LD) between selected SNPs was estimated in the control population of population-based studies using SNP_Tools, version 1.70 (<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047522">Chen <em>et al.</em> 2009a</a>) and Haploview, version 4.2 (<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047495">Barrett <em>et al.</em> 2005</a>).</p><p id="P18">The association between current MHT use and SNPs was assessed utilizing data of all studies of the replication stage as well as solely population-based studies. We fitted a logistic regression model adjusted for study with current MHT use as the outcome.</p><p id="P19">To illustrate the modification of overall as well as lobular breast cancer risk associated with current use of MHT by SNPs, the effect of current use of MHT was assessed in strata defined by the SNP genotype in pooled case-control data of the replication stage. The models were adjusted for study, reference age, former use of MHT and the two previously described interaction terms to account for possible differences in the estimates of the MHT effect according to study design.</p><p id="P20" class="p p-last">To further evaluate the effect modification of current use of MHT by multiple modifying loci, a polygenic score was built for each individual. For the genetic score, we included the genetic loci found to modify the association with current use of MHT at a significance level of <em>P</em><sub>int</sub> &lt;5.0×10<sup>−05</sup> and selected one SNP per region based on the effect estimate. The allele increasing the effect of MHT on breast cancer risk was used as risk allele and the polygenic score was derived by summing up the risk alleles (0, 1 or 2) for each SNP. Separate scores were constructed for overall and lobular breast cancer risk. To demonstrate the polygenic modifying effect, associations of current MHT use with breast cancer risk were calculated stratified by score categories (roughly quintiles for all breast cancers and tertiles for lobular tumors). The respective logistic regression models were adjusted for study, reference age, former use of MHT, an interaction term between former use of MHT and study design (non-population-based vs. population-based) and an interaction term between current use of MHT and study design.</p></div></div><div id="S10" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S10title">RESULTS</h2><p id="P21" class="p p-first">Characteristics of the patients participating in the studies included in the discovery stage and the replication stage are shown in <a href="#SD9" rid="SD9" class=" supplementary-material">Supplementary Table 2</a> and <a href="#SD10" rid="SD10" class=" supplementary-material">Supplementary Table 3</a>. The prevalence of current use of MHT varied between 10% and 60%. The estimated OR for the marginal effect of current use of MHT in the population-based studies of the replication stage was 1.51 (95% CI 1.21 – 1.88) for overall breast cancer and 1.83 (95% CI 1.34 – 2.47) for lobular breast cancer, as displayed in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 1</a>.</p><p id="P22">The meta-analysis of the case-only genome-wide studies did not identify any SNPxMHT interaction at genome-wide significance level (see <a href="#SD2" rid="SD2" class=" supplementary-material">Supplementary Figure 2</a> and <a href="#SD3" rid="SD3" class=" supplementary-material">Supplementary Figure 3</a>, respectively, for quantile-quantile (QQ) and Manhattan plots of the results). The strongest association was observed for rs3824418 located in and intronic region of <em>TLE1</em> on 9q21.3 (<em>P</em><sub>int</sub> = 6.7×10<sup>−07</sup>.</p><p id="P23">Of the 1,391 SNPs carried forward for replication, 944 were selected based on their <em>P</em><sub>int</sub> for modification of overall breast cancer risk associated with MHT, and 447 based on their <em>P</em><sub>int</sub> for modification of lobular breast cancer risk. Overall, 7 SNPs showed effect modification of overall breast cancer with combined <em>P</em><sub>int</sub> &lt;5.0×10<sup>−05</sup>, as well as 7 SNPs with respect to lobular breast cancer risk (<a href="/pmc/articles/PMC3863710/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). There was no strong association between the SNPs selected for follow-up and current use of MHT, as can be seen from QQ-plots in <a href="#SD4" rid="SD4" class=" supplementary-material">Supplementary Figure 4</a>. When analyzing the whole sample of the replication stage, the SNPs showing strongest association with current use of MHT were rs12538442, located in an intronic region of DOCK4 on chromosome 1 (<em>P</em> = 3.1×10<sup>−04</sup>), and rs17738984, located on chromosome 17q22 (<em>P</em> = 8.8×10<sup>−04</sup>). The SNPs showing the strongest association with MHT use when restricting the sample to population-based studies were rs10924245 in <em>KIF26B</em> (<em>P</em> = 1.6×10<sup>−04</sup>) and rs2102354 in <em>KCNN3</em> (<em>P</em> = 7.7×10<sup>−04</sup>), both located on chromosome 1.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p20">Odds ratios of multiplicative interaction between current menopausal hormone therapy use and SNPs for overall and lobular breast cancer risk</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140558568418464" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="middle" align="left">SNP</th><th rowspan="2" colspan="1" valign="middle" align="center">Chr</th><th rowspan="2" colspan="1" valign="middle" align="center">Position (build 37)</th><th rowspan="2" colspan="1" valign="middle" align="center">RefSeq Gene</th><th rowspan="2" colspan="1" valign="middle" align="center">Feature</th><th colspan="2" rowspan="1" valign="middle" align="center">GWAS<sup>a</sup></th><th colspan="2" rowspan="1" valign="middle" align="center">REPLICATION</th><th colspan="2" rowspan="1" valign="middle" align="center">COMBINED<sup>c</sup></th></tr><tr><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em><sub>int</sub></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)<sup>b</sup></th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em><sub>int</sub></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em><sub>int</sub></th></tr></thead><tbody><tr><td colspan="11" rowspan="1" valign="top" align="left"><strong><em>Overall breast cancer</em></strong></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs9578047</td><td rowspan="1" colspan="1" valign="top" align="center">13</td><td rowspan="1" colspan="1" valign="top" align="center">29164731</td><td rowspan="1" colspan="1" valign="top" align="center">68kb 5′ of POMP</td><td rowspan="1" colspan="1" valign="top" align="center">-</td><td rowspan="1" colspan="1" valign="top" align="center">0.81 (0.72 – 0.91)</td><td rowspan="1" colspan="1" valign="top" align="center">6.3×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.84 (0.75 – 0.95)</td><td rowspan="1" colspan="1" valign="top" align="center">3.6×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.83 (0.76 – 0.90)</td><td rowspan="1" colspan="1" valign="top" align="center">7.9×10<sup>−06</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs9579199</td><td rowspan="1" colspan="1" valign="top" align="center">13</td><td rowspan="1" colspan="1" valign="top" align="center">29164783</td><td rowspan="1" colspan="1" valign="top" align="center">68kb 5′ of POMP</td><td rowspan="1" colspan="1" valign="top" align="center">-</td><td rowspan="1" colspan="1" valign="top" align="center">0.81 (0.72 – 0.91)</td><td rowspan="1" colspan="1" valign="top" align="center">6.3×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.84 (0.75 – 0.95)</td><td rowspan="1" colspan="1" valign="top" align="center">3.4×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.83 (0.76 – 0.90)</td><td rowspan="1" colspan="1" valign="top" align="center">7.6×10<sup>−06</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs7148646</td><td rowspan="1" colspan="1" valign="top" align="center">14</td><td rowspan="1" colspan="1" valign="top" align="center">37407036</td><td rowspan="1" colspan="1" valign="top" align="center">SLC25A21</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">0.80 (0.70 – 0.90)</td><td rowspan="1" colspan="1" valign="top" align="center">3.7×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.85 (0.76 – 0.96)</td><td rowspan="1" colspan="1" valign="top" align="center">7.4×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.83 (0.76 – 0.90)</td><td rowspan="1" colspan="1" valign="top" align="center">1.2×10<sup>−05</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs848694</td><td rowspan="1" colspan="1" valign="top" align="center">14</td><td rowspan="1" colspan="1" valign="top" align="center">37371724</td><td rowspan="1" colspan="1" valign="top" align="center">SLC25A21</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">0.80 (0.70 – 0.91)</td><td rowspan="1" colspan="1" valign="top" align="center">9.4×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.86 (0.76 – 0.97)</td><td rowspan="1" colspan="1" valign="top" align="center">1.3×10<sup>−02</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.83 (0.76 – 0.91)</td><td rowspan="1" colspan="1" valign="top" align="center">4.6×10<sup>−05</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs7192724</td><td rowspan="1" colspan="1" valign="top" align="center">16</td><td rowspan="1" colspan="1" valign="top" align="center">81958298</td><td rowspan="1" colspan="1" valign="top" align="center">PLCG2</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">1.24 (1.09 – 1.42)</td><td rowspan="1" colspan="1" valign="top" align="center">1.3×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.24 (1.09 – 1.40)</td><td rowspan="1" colspan="1" valign="top" align="center">7.8×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.24 (1.13 – 1.36)</td><td rowspan="1" colspan="1" valign="top" align="center">3.3×10<sup>−06</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs17202296</td><td rowspan="1" colspan="1" valign="top" align="center">16</td><td rowspan="1" colspan="1" valign="top" align="center">81959191</td><td rowspan="1" colspan="1" valign="top" align="center">PLCG2</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">1.28 (1.13 – 1.46)</td><td rowspan="1" colspan="1" valign="top" align="center">1.4×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.14 (1.01 – 1.29)</td><td rowspan="1" colspan="1" valign="top" align="center">2.9×10<sup>−02</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.21 (1.10 – 1.32)</td><td rowspan="1" colspan="1" valign="top" align="center">2.8×10<sup>−05</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs4888190</td><td rowspan="1" colspan="1" valign="top" align="center">16</td><td rowspan="1" colspan="1" valign="top" align="center">81963618</td><td rowspan="1" colspan="1" valign="top" align="center">PLCG2</td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">1.32 (1.16 – 1.5)</td><td rowspan="1" colspan="1" valign="top" align="center">3.8×10<sup>−05</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.11 (0.99 – 1.26)</td><td rowspan="1" colspan="1" valign="top" align="center">8.0×10<sup>−02</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.20 (1.10 – 1.31)</td><td rowspan="1" colspan="1" valign="top" align="center">4.5×10<sup>−05</sup></td></tr><tr><td colspan="11" rowspan="1" valign="top" align="left"><strong><em>Lobular breast cancer</em></strong></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs11680872</td><td rowspan="1" colspan="1" valign="top" align="center">2</td><td rowspan="1" colspan="1" valign="top" align="center">192830249</td><td rowspan="1" colspan="1" valign="top" align="center"><em>TMEFF2</em></td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">2.01 (1.40 – 2.87)</td><td rowspan="1" colspan="1" valign="top" align="center">1.5×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.40 (1.05 – 1.87)</td><td rowspan="1" colspan="1" valign="top" align="center">1.9×10<sup>−02</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.61 (1.29 – 2.01)</td><td rowspan="1" colspan="1" valign="top" align="center">2.9×10<sup>−05</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs7648642</td><td rowspan="1" colspan="1" valign="top" align="center">3</td><td rowspan="1" colspan="1" valign="top" align="center">119261375</td><td rowspan="1" colspan="1" valign="top" align="center"><em>CD80</em></td><td rowspan="1" colspan="1" valign="top" align="center">intronic</td><td rowspan="1" colspan="1" valign="top" align="center">0.58 (0.43 – 0.79)</td><td rowspan="1" colspan="1" valign="top" align="center">4.6×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.68 (0.54 – 0.87)</td><td rowspan="1" colspan="1" valign="top" align="center">2.3×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.64 (0.53 – 0.78)</td><td rowspan="1" colspan="1" valign="top" align="center">5.1×10<sup>−06</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs11654964</td><td rowspan="1" colspan="1" valign="top" align="center">17</td><td rowspan="1" colspan="1" valign="top" align="center">32989538</td><td rowspan="1" colspan="1" valign="top" align="center">23kb 3′ of <em>TMEM132E</em></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">1.76 (1.30 – 2.38)</td><td rowspan="1" colspan="1" valign="top" align="center">2.7×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.58 (1.17 – 2.14)</td><td rowspan="1" colspan="1" valign="top" align="center">2.4×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.67 (1.35 – 2.06)</td><td rowspan="1" colspan="1" valign="top" align="center">2.7×10<sup>−06</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs16970162</td><td rowspan="1" colspan="1" valign="top" align="center">17</td><td rowspan="1" colspan="1" valign="top" align="center">32989786</td><td rowspan="1" colspan="1" valign="top" align="center">23kb 3′ of <em>TMEM132E</em></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">1.85 (1.34 – 2.54)</td><td rowspan="1" colspan="1" valign="top" align="center">1.5×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.49 (1.09 – 2.05)</td><td rowspan="1" colspan="1" valign="top" align="center">1.1×10<sup>−02</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.66 (1.33 – 2.07)</td><td rowspan="1" colspan="1" valign="top" align="center">8.6×10<sup>−06</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs11080292</td><td rowspan="1" colspan="1" valign="top" align="center">17</td><td rowspan="1" colspan="1" valign="top" align="center">32998577</td><td rowspan="1" colspan="1" valign="top" align="center">32kb 3′ of <em>TMEM132E</em></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">1.77 (1.29 – 2.44)</td><td rowspan="1" colspan="1" valign="top" align="center">4.6×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.57 (1.14 – 2.15)</td><td rowspan="1" colspan="1" valign="top" align="center">4.9×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.66 (1.33 – 2.08)</td><td rowspan="1" colspan="1" valign="top" align="center">9.3×10<sup>−06</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs6506940</td><td rowspan="1" colspan="1" valign="top" align="center">18</td><td rowspan="1" colspan="1" valign="top" align="center">29333635</td><td rowspan="1" colspan="1" valign="top" align="center">6kb 3′ of <em>SLC25A52</em></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">2.06 (1.35 – 3.13)</td><td rowspan="1" colspan="1" valign="top" align="center">7.2×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.80 (1.19 – 2.71)</td><td rowspan="1" colspan="1" valign="top" align="center">4.0×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.92 (1.43 – 2.58)</td><td rowspan="1" colspan="1" valign="top" align="center">1.2×10<sup>−05</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs594334</td><td rowspan="1" colspan="1" valign="top" align="center">18</td><td rowspan="1" colspan="1" valign="top" align="center">29364523</td><td rowspan="1" colspan="1" valign="top" align="center">24kb 5′ of <em>SLC25A52</em></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">1.92 (1.25 – 2.94)</td><td rowspan="1" colspan="1" valign="top" align="center">3.0×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.85 (1.22 – 2.81)</td><td rowspan="1" colspan="1" valign="top" align="center">3.0×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.88 (1.40 – 2.54)</td><td rowspan="1" colspan="1" valign="top" align="center">3.4×10<sup>−05</sup></td></tr></tbody></table></div><div id="largeobj_idm140558568418464" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3863710/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>a</sup>fixed effects meta analysis of results from four case-only GWAS</div><div id="TFN2"><sup>b</sup>adjusted for study, reference age, former use of menopausal hormone therapy, interaction terms between study design (population-bases vs. non-population-based) and former use and current of menopausal hormone therapy, as well as genetic principal components</div><div id="TFN3"><sup>c</sup>fixed effects meta-analysis of results from GWAS and replication analysis</div></div></div><p id="P24">Further information on SNPs, including their association with overall breast cancer risk in the replication dataset and MAFs in the different study populations can be found in <a href="#SD11" rid="SD11" class=" supplementary-material">Supplementary Table 4</a>. The identified SNPs on each of the chromosomes 13, 14, 16, 17 and 18 are located in close proximity to each other and do not represent independent signals of genetic modification of the MHT effect. The respective LD plots can be found in <a href="#SD5" rid="SD5" class=" supplementary-material">Supplementary Figure 5</a>.</p><p id="P25">For overall breast cancer risk, two SNPs (rs9578047 and rs9579199) near <em>POMP</em> on chromosome 13 showed an interaction with current use of MHT with combined <em>P</em><sub>int</sub> = 7.9×10<sup>−06</sup> and 7.6×10<sup>−06</sup>. SNPxMHT interactions with <em>P</em><sub>int</sub> of similar magnitude were also observed with rs7148646 and rs848694 in <em>SLC25A21</em> on chromosome 14 (combined <em>P</em><sub>int</sub> = 1.2×10<sup>−05</sup> and 4.6×10<sup>−05</sup>) and three SNPs (rs7192724, rs17202296, and rs4888190) in <em>PLCG2</em> on chromosome 16 (combined <em>P</em><sub>int</sub> = 3.3×10<sup>−06</sup>, 2.8×10<sup>−05</sup> and 4.5×10<sup>−05</sup>) (<a href="/pmc/articles/PMC3863710/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). Associations between current use of MHT and overall breast cancer risk stratified by genotypes of these SNPs are displayed in <a href="/pmc/articles/PMC3863710/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>. We did not observe significantly heterogeneous SNPxMHT interactions between studies that were pooled in the replication stage (<em>P</em><sub>het</sub> ranging from 0.16 to 0.91). The respective forest plots are shown in <a href="#SD6" rid="SD6" class=" supplementary-material">Supplementary Figure 6</a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p24">Association between current use of menopausal hormone therapy and overall as well as lobular breast cancer risk stratified by genotype</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140558572850528" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="middle" align="center">SNP</th><th colspan="2" rowspan="1" valign="middle" align="center">Alleles<sup>a</sup></th><th colspan="2" rowspan="1" valign="middle" align="center">Homozygous reference</th><th colspan="2" rowspan="1" valign="middle" align="center">Heterozygous</th><th colspan="2" rowspan="1" valign="middle" align="center">Homozygous coded</th></tr><tr><th rowspan="1" colspan="1" valign="middle" align="center">Reference</th><th rowspan="1" colspan="1" valign="middle" align="center">Coded</th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)<sup>b</sup></th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)<sup>b</sup></th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">OR (95% CI)<sup>b</sup></th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th></tr></thead><tbody><tr><td colspan="9" rowspan="1" valign="top" align="left"><strong><em>Overall breast cancer</em></strong></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs9578047</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">1.91 (1.46 – 2.50)</td><td rowspan="1" colspan="1" valign="top" align="center">2.0×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.50 (1.30 – 1.72)</td><td rowspan="1" colspan="1" valign="top" align="center">1.3×10<sup>−08</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.30 (1.14 – 1.48)</td><td rowspan="1" colspan="1" valign="top" align="center">6.4×10<sup>−05</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs9579199</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">1.92 (1.47 – 2.51)</td><td rowspan="1" colspan="1" valign="top" align="center">1.8×10<sup>−06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.50 (1.30 – 1.72)</td><td rowspan="1" colspan="1" valign="top" align="center">1.4×10<sup>−08</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.30 (1.14 – 1.48)</td><td rowspan="1" colspan="1" valign="top" align="center">6.5×10<sup>−05</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs7148646</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">1.58 (1.39 – 1.80)</td><td rowspan="1" colspan="1" valign="top" align="center">1.9×10<sup>−12</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.24 (1.08 – 1.43)</td><td rowspan="1" colspan="1" valign="top" align="center">2.6×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.31 (1.10 – 1.73)</td><td rowspan="1" colspan="1" valign="top" align="center">5.2×10<sup>−02</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs848694</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">1.55 (1.37 – 1.75)</td><td rowspan="1" colspan="1" valign="top" align="center">3.2×10<sup>−12</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.23 (1.06 – 1.43)</td><td rowspan="1" colspan="1" valign="top" align="center">5.8×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.34 (0.97 – 1.85)</td><td rowspan="1" colspan="1" valign="top" align="center">7.5×10<sup>−02</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs7192724</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">1.10 (0.78 – 1.54)</td><td rowspan="1" colspan="1" valign="top" align="center">5.9×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.25 (1.09 – 1.44)</td><td rowspan="1" colspan="1" valign="top" align="center">1.9×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.58 (1.40 – 1.80)</td><td rowspan="1" colspan="1" valign="top" align="center">7.8×10<sup>−13</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs17202296</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">1.19 (0.88 – 1.62)</td><td rowspan="1" colspan="1" valign="top" align="center">2.5×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.32 (1.15 – 1.51)</td><td rowspan="1" colspan="1" valign="top" align="center">1.1×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.53 (1.35 – 1.74)</td><td rowspan="1" colspan="1" valign="top" align="center">7.0×10<sup>−11</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs4888190</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">1.22 (0.89 – 1.66)</td><td rowspan="1" colspan="1" valign="top" align="center">2.1×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.36 (1.18 – 1.57)</td><td rowspan="1" colspan="1" valign="top" align="center">1.5×10<sup>−05</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.52 (1.34 – 1.73)</td><td rowspan="1" colspan="1" valign="top" align="center">1.3×10<sup>−10</sup></td></tr><tr><td colspan="9" rowspan="1" valign="top" align="left"><strong><em>Lobular breast cancer</em></strong></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs11680872</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">1.33 (0.64 – 2.76)</td><td rowspan="1" colspan="1" valign="top" align="center">4.5×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.42 (1.04 – 1.94)</td><td rowspan="1" colspan="1" valign="top" align="center">2.6×10<sup>−02</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.19 (1.70 – 2.82)</td><td rowspan="1" colspan="1" valign="top" align="center">1.3×10<sup>−09</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs7648642</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">3.05 (2.10 – 4.42)</td><td rowspan="1" colspan="1" valign="top" align="center">4.1×10<sup>−09</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.62 (1.23 – 2.14)</td><td rowspan="1" colspan="1" valign="top" align="center">6.0×10<sup>−04</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.43 (1.01 – 2.02)</td><td rowspan="1" colspan="1" valign="top" align="center">4.3×10<sup>−02</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs11654964</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.24 (0.06 – 1.04)</td><td rowspan="1" colspan="1" valign="top" align="center">5.7×10<sup>−02</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.61 (1.18 – 2.19)</td><td rowspan="1" colspan="1" valign="top" align="center">2.8×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.15 (1.68 – 2.76)</td><td rowspan="1" colspan="1" valign="top" align="center">1.7×10<sup>−09</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs16970162</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.33 (0.07 – 1.47)</td><td rowspan="1" colspan="1" valign="top" align="center">1.5×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.57 (1.14 – 2.17)</td><td rowspan="1" colspan="1" valign="top" align="center">6.3×10<sup>−03</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.09 (1.64 – 2.66)</td><td rowspan="1" colspan="1" valign="top" align="center">3.0×10<sup>−09</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs11080292</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">0.38 (0.08 – 1.70)</td><td rowspan="1" colspan="1" valign="top" align="center">2.0×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.47 (1.06 – 2.03)</td><td rowspan="1" colspan="1" valign="top" align="center">2.1×10<sup>−02</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.15 (1.69 – 2.74)</td><td rowspan="1" colspan="1" valign="top" align="center">6.5×10<sup>−10</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs6506940</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.94 (0.10 – 8.90)</td><td rowspan="1" colspan="1" valign="top" align="center">9.6×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.08 (0.72 – 1.61)</td><td rowspan="1" colspan="1" valign="top" align="center">7.2×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.05 (1.63 – 2.58)</td><td rowspan="1" colspan="1" valign="top" align="center">7.4×10<sup>−10</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs594334</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">1.40 (0.24 – 7.98)</td><td rowspan="1" colspan="1" valign="top" align="center">7.1×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.03 (0.68 – 1.58)</td><td rowspan="1" colspan="1" valign="top" align="center">8.7×10<sup>−01</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.09 (1.67 – 2.61)</td><td rowspan="1" colspan="1" valign="top" align="center">1.6×10<sup>−10</sup></td></tr></tbody></table></div><div id="largeobj_idm140558572850528" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3863710/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN4"><sup>a</sup>the coded allele was not necessarily the minor allele.</div><div id="TFN5"><sup>b</sup>adjusted for study, reference age, former use of menopausal hormone therapy, interaction between former use of menopausal hormone therapy and study design (non-population-based vs. population-based) and interaction between current use of menopausal hormone therapy and study design</div></div></div><p id="P26">We combined rs7148646_G, rs9579199_G, and rs7192724_G and constructed a polygenic score to assess breast cancer risk associated with current use of MHT depending on the modifying genetic risk (number of risk modifying alleles) (<a href="/pmc/articles/PMC3863710/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2A</span></a>). For women with a low polygenic score of two or less risk modifying alleles (16.7% of women), current use of MHT was not associated with an increased breast cancer risk (OR = 1.04, 95% CI 0.87 – 1.25). Among women carrying three (30.9% of women) or four (34.2% of women) risk modifying alleles, current use of MHT was associated with a significantly increased breast cancer risk (OR = 1.25, 95% CI 1.08 – 1.45 and OR = 1.57, 95% CI 1.36 – 1.80, respectively). The strongest association between current use of MHT and breast cancer risk was observed for women with a polygenic score of five or six (18.2% of women) (OR = 1.86, 95% CI 1.56 – 2.22), as expected.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3863710/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140558568421200" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms529599f2.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms529599f2.jpg" src="/pmc/articles/PMC3863710/bin/nihms529599f2.jpg"></div></a><div id="largeobj_idm140558568421200" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC3863710/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a target="object" href="/pmc/articles/PMC3863710/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3863710/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p19">Odd ratios for (A) overall breast cancer and (B) lobular breast cancer risk associated with current use of menopausal hormone therapy in categories defined by polygenic scores</p></div></div></div><p id="P27">With respect to lobular breast cancer, the variant rs11680872 located in an intronic region of <em>TMEFF2</em> on chromosome 2 showed a SNPxMHT interaction with combined <em>P</em><sub>int</sub> = 2.9×10<sup>−05</sup> (Table 3). Also, rs7648642 in <em>CD80</em> on chromosome 3 modified MHT associated lobular breast cancer risk in both case-only and case-control analysis (combined <em>P</em><sub>int</sub> = 5.1×10<sup>−06</sup>). The variants rs11654964, rs16970162 and rs11080292 located near <em>TMEM132E</em> on chromosome 17 yielded combined <em>P</em><sub>int</sub> of 2.7×10<sup>−06</sup>, 8.6×10<sup>−06</sup> and 9.3×10<sup>−06</sup>, respectively. Further SNPxMHT interactions were observed for rs6506940 and rs594334 near <em>SLC25A52</em> on chromosome 18 (combined <em>P</em><sub>int</sub> = 1.2×10<sup>−05</sup> and 3.4×10<sup>−05</sup>, respectively) (<a href="/pmc/articles/PMC3863710/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). <a href="/pmc/articles/PMC3863710/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a> shows the associations between current use of MHT and lobular breast cancer risk in strata defined by genotypes of these SNPs. There was no significant heterogeneity by study in the estimates for SNPxMHT interactions (<em>P</em><sub>het</sub> ranging from 0.22 to 0.94). The respective forest plots are shown in <a href="#SD7" rid="SD7" class=" supplementary-material">Supplementary Figure 7</a>.</p><p id="P28" class="p p-last">For lobular breast cancer risk, a polygenic score was constructed by combining rs11680872_A, rs7648642_C, rs11654964_A, and rs6506940_A (<a href="/pmc/articles/PMC3863710/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2B</span></a>). Current use of MHT was not associated with increased lobular breast cancer risk in women carrying zero to four risk modifying alleles (15.2% of women, OR = 0.61, 95% CI 0.35 – 1.07), while the OR for lobular breast cancer risk was 1.64 (95% CI 1.18 – 2.26) in the subgroup (25.5% of women) carrying five risk modifying alleles. The association with current MHT use increased with the polygenic score and the odds ratio for lobular breast cancer was 2.20 (95% CI 1.66 – 2.92) in women with a polygenic score of six (30.9% of women) and 2.38, 95% CI 1.78 – 3.18) in those carrying seven or eight risk modifying alleles (25.8% of women).</p></div><div id="S11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S11title">DISCUSSION</h2><p id="P29" class="p p-first">Using a two stage approach consisting of a meta-analysis of four case-only genome-wide association studies and a replication analysis in independent data of ten case-control studies, we attempted to identify SNPs that modify the effect of MHT use on breast cancer risk. Despite our large sample size in both discovery and replication stages, we did not identify any SNPs that reached genome-wide significance. We observed three loci on chromosome 13, 14 and 16 that modified MHT associated overall breast cancer risk in both the discovery and replication stage, with combined <em>P</em><sub>int</sub> &lt;5.0×10<sup>−05</sup>. Additionally, four genomic loci on chromosome 2, 3, 17 and 18 modified lobular breast cancer risk associated with MHT use in both study stages at the same significance level.</p><p id="P30">When combining variants that modify the effect of current use of MHT in a polygenic score, current MHT use was associated with an 86% increased breast cancer risk among women with five to six risk modifying alleles (18.2% of all women included in the study) and was not associated with breast cancer risk among women carrying two or less (16.7% of women). Women with a polygenic score of three or four that were currently using MHT were at an intermediate increased risk of breast cancer. Similar results were observed for lobular breast cancer risk. Given the observed interactions are confirmed, the polygenic score illustrates that even though the single detected interactions might be modest, the associated breast cancer risk for a woman using MHT may be appreciably increased if she carries a large number of adverse risk modifying alleles.</p><p id="P31">The loci of the identified polymorphisms provide indication of possible biological relevance for breast carcinogenesis. Two variants rs9579199 and rs9578047 close to <em>FLT1</em> and <em>POMP</em> on chromosome 13 showed modifying effects on MHT associated breast cancer risk. FLT1 is a vascular endothelial growth factor receptor and involved in tumor angiogenesis (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047503">Fischer <em>et al.</em> 2008</a>). So far, no association has been reported between tumor development and POMP, a proteasome maturation protein. The variants on chromosome 14 (rs7148646, rs848694) lie in an intronic region of <em>SLC25A21. SLC25A21</em> encodes an oxodicarboxylate carrier, which transports C5–C7 oxodicarboxylates across the inner membranes of mitochondria (<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047491">Fiermonte <em>et al.</em> 2001</a>). Interestingly, the two SNPs rs6506940 and rs594334 found to modify risk of lobular breast cancer are located near another mitochondrial carrier gene, <em>SLC25A52</em>, on chromosome 18. Estrogen has been reported to be an important regulator of mitochondrial function (<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047521">Chen <em>et al.</em> 2009b</a>) and results of the present study suggest that mitochondrial related mechanisms may play a role in MHT associated breast carcinogenesis. The association between MHT and breast cancer was also modified by rs7192724, rs17202296 and rs4888190 located in intronic regions of <em>PLCG2</em>. PLCG2 is a member of the phosphoinositide-specific phospholipase C family and is involved in transmitting activation signals across the cell membranes predominantly of B cells (<a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047509">Wang <em>et al.</em> 2000</a>) as well as natural killer cells (<a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047475">Tassi <em>et al.</em> 2005</a>).</p><p id="P32">With respect to lobular breast cancer, genetic variants in two transmembrane proteins were implicated. rs11680872 is located in an intron of <em>TMEFF2,</em> whose biological function is unclear but its promoter region has been commonly found to be hypermethylated in various cancers, including breast cancer (<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047524">Lin <em>et al.</em> 2011</a>; <a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047518">Park <em>et al.</em> 2011</a>). Three variants (rs11654964, rs16970162 and rs11080292) are near (23–32kb 3′) <em>TMEM132E</em>, another transmembrane protein. We observed also an interaction with rs7648642, which lies in an intron of <em>CD80</em> on chromosome 3. CD80 is known to play an important role in T cell activation (<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047485">Bhatia <em>et al.</em> 2006</a>), and its expression has been found to be decreased in peripheral blood of breast cancer patients (<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047484">Gong <em>et al.</em> 2012</a>).</p><p id="P33">To account for differences by country with respect to types of preparations and dosages as well as different genotype platforms and laboratories, we used meta-analysis to combine the results in the discovery stage and adjusted for study in the replication stage. Heterogeneity of estimates regarding MHT use between studies due to differences in the study design were in part accounted for by adding an interaction term between MHT use and study design in the regression models (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 1</a>). The sensitivity analysis restricted to solely population-based studies of the replication stage for selected SNPxMHT interactions did not yield substantially altered estimates for interaction (less than 7.5% for overall breast cancer and less than 11.5% for lobular breast cancer, <a href="#SD12" rid="SD12" class=" supplementary-material">Supplementary Table 5</a>). Utilizing the total study population of the replication stage, the study had 80% power to detect an interaction effect of 1.20, assuming an allele frequency of 20%, a marginal genetic effect of 1.15 and a marginal effect of current MHT use of 1.35. The power was reduced to 55% when restricting the sample to population-based studies. Furthermore, although the associations between current MHT use and breast cancer risk observed in the single studies were heterogeneous, this was not the case for the SNPxMHT interactions (<a href="#SD6" rid="SD6" class=" supplementary-material">Supplementary Figure 6</a> and <a href="#SD7" rid="SD7" class=" supplementary-material">7</a>). In general, estimates for gene-environment interaction are unlikely to be affected by selection bias (<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047483">Morimoto <em>et al.</em> 2003</a>) and more likely to be underestimated in the presence of non-differential or differential misclassification (<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047482">Garcia-Closas <em>et al.</em> 1999</a>).</p><p id="P34">Most of the reported genetic modifiers of MHT associated breast cancer risk have so far not been followed up in further studies (<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047526">Justenhoven <em>et al.</em> 2012</a>). One exception is with respect to variants in <em>FGFR2</em>, since it is also a know breast cancer susceptibility loci. Rebbeck et al. reported that the association between combined estrogen-progestogen therapy and breast cancer risk was modified by rs1219648 in postmenopausal women of European descent (<em>P</em><sub>int</sub> = 0.010) (<a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047508">Rebbeck <em>et al.</em> 2009</a>). A study conducted in participants of the Women’s Health Initiative trial could not replicate this finding (<em>P</em><sub>int</sub> = 0.661) but observed an interaction with rs3750817 in <em>FGFR2</em> (<em>P</em><sub>int</sub> = 0.033) (<a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047533">Prentice <em>et al.</em> 2009</a>). A similar modifying effect of this SNP was also observed for estrogen-monotherapy (<em>P</em><sub>int</sub> = 0.046). The variants rs1219648 and rs3750817 are in moderate LD (r<sup>2</sup> = 0.44, D′ = 1.00). However, we did not observe an interaction regarding breast cancer risk with current use of any MHT and rs1219648 (<em>P</em><sub>int</sub> = 0.15) or rs3750817 (<em>P</em><sub>int</sub> = 0.23) in the genome-wide association study and the variants were not followed up in the replication stage. Similarly, no significant interactions were observed with <em>FGRR2</em> variants in more recent studies (<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047498">Andersen <em>et al.</em> 2012</a>; <a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047507">Campa <em>et al.</em> 2011</a>; <a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047502">Nickels <em>et al.</em> 2013</a>).</p><p id="P35">Genome-wide studies of gene-environment interactions present challenges since the required sample size maybe inflated due to misclassification of environmental exposures and additional factors involved including effect size of gene-environment interaction and prevalence of environmental exposure(s) (<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047525">Dempfle <em>et al.</em> 2008</a>; <a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047528">Zondervan and Cardon 2004</a>). To optimize power, we used the case-only approach in the discovery stage, which offers greater precision in estimating the interaction term, and the case-control approach in the replication stage to account for false positive results due to correlation of the environmental exposure with the genetic marker in the population (<a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_411047513">Piegorsch <em>et al.</em> 1994</a>). There was no indication of strong associations between SNPs selected for follow-up and current use of MHT (<a href="#SD4" rid="SD4" class=" supplementary-material">Supplementary Figure 4</a>), supporting the assumption of gene-environment independence. We minimized possible spurious associations due to differences in allele frequencies in the underlying populations by restriction to solely individuals of European descent. The observed genomic inflation in the case-only studies was close to one and the case-control analyses were controlled for population stratification by including genetic principal components.</p><p id="P36" class="p p-last">In conclusion, the association between current use of MHT and risk of overall and lobular breast cancer is potentially modified by genetic variants in genes related to mitochondrial solute carriers, transmembrane signaling as well as immune cell activation. These findings need replication in independent studies of adequate power. The identified modest interaction effects are presently unlikely to be of clinical significance, but provide valuable insight into potential mechanisms of breast cancer development.</p></div><div id="S12" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S12title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="d36e1645"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-1.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(63K, doc)</sup></div></div><div class="sec suppmat" id="SD2"><h4>10</h4><div class="sup-box half_rhythm" id="d36e1649"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-10.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(68K, doc)</sup></div></div><div class="sec suppmat" id="SD3"><h4>11</h4><div class="sup-box half_rhythm" id="d36e1653"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-11.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(54K, doc)</sup></div></div><div class="sec suppmat" id="SD4"><h4>12</h4><div class="sup-box half_rhythm" id="d36e1657"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-12.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(56K, doc)</sup></div></div><div class="sec suppmat" id="SD5"><h4>2</h4><div class="sup-box half_rhythm" id="d36e1661"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-2.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(60K, doc)</sup></div></div><div class="sec suppmat" id="SD6"><h4>3</h4><div class="sup-box half_rhythm" id="d36e1665"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-3.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(465K, doc)</sup></div></div><div class="sec suppmat" id="SD7"><h4>4</h4><div class="sup-box half_rhythm" id="d36e1669"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-4.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(46K, doc)</sup></div></div><div class="sec suppmat" id="SD8"><h4>5</h4><div class="sup-box half_rhythm" id="d36e1673"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-5.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(46K, pdf)</sup></div></div><div class="sec suppmat" id="SD9"><h4>6</h4><div class="sup-box half_rhythm" id="d36e1677"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-6.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(211K, pdf)</sup></div></div><div class="sec suppmat" id="SD10"><h4>7</h4><div class="sup-box half_rhythm" id="d36e1681"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-7.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(180K, pdf)</sup></div></div><div class="sec suppmat" id="SD11"><h4>8</h4><div class="sup-box half_rhythm" id="d36e1686"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-8.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(60K, doc)</sup></div></div><div class="sec suppmat" id="SD12"><h4>9</h4><div class="sup-box half_rhythm" id="d36e1690"><a href="/pmc/articles/PMC3863710/bin/NIHMS529599-supplement-9.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(41K, doc)</sup></div></div></div><div id="S13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S13title">Acknowledgments</h2><div class="sec"><p id="__p1"><strong>FUNDING</strong></p><p id="__p2">Funding for the iCOGS infrastructure came from: the European Community’s Seventh Framework Programme under grant agreement n° 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, <a id="__tag_810965307" class="tag_hotlink" href="/nuccore/C12292" ref="/nuccore/C12292"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"C12292","term_id":"1559845","term_text":"C12292"}}</span>C12292</a>/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692), the National Institutes of Health (<a id="__tag_810965308" class="tag_hotlink" href="/nuccore/CA128978" ref="/nuccore/CA128978"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA128978","term_id":"35010393","term_text":"CA128978"}}</span>CA128978</a>) and Post-Cancer GWAS initiative (1U19 <a id="__tag_810965306" class="tag_hotlink" href="/nuccore/CA148537" ref="/nuccore/CA148537"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA148537","term_id":"35049674","term_text":"CA148537"}}</span>CA148537</a>, 1U19 <a id="__tag_810965301" class="tag_hotlink" href="/nuccore/CA148065" ref="/nuccore/CA148065"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA148065","term_id":"35048730","term_text":"CA148065"}}</span>CA148065</a> and 1U19 <a id="__tag_810965303" class="tag_hotlink" href="/nuccore/CA148112" ref="/nuccore/CA148112"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA148112","term_id":"35048823","term_text":"CA148112"}}</span>CA148112</a> - the GAME- ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund.</p><p id="__p3">Meetings of the BCAC have been funded by the European Union COST programme (BM0606). D.F.E. is a Principal Research Fellow of CR-UK.</p><p id="__p4">The CECILE study was funded by the Fondation de France; the French National Institute of Cancer (INCa); The National League against Cancer; the National Agency for Environmental and Occupational Health and Food Safety (ANSES), the National Agency for Research (ANR), and the Association for Research against Cancer (ARC).</p><p id="__p5">The GENICA was funded by the Federal Ministry of Education and Research (BMBF) Germany grants 01KW9975/5, 01KW9976/8, 01KW9977/0 and 01KW0114 as well as 01KH0401, 01KH0410, 01KH0411, the Robert Bosch Foundation, Stuttgart, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum, as well as the Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.</p><p id="__p6">The MARIE study was supported by the Deutsche Krebshilfe e.V. [70-2892-BR I], the Hamburg Cancer Society, the German Cancer Research Center and genotype work in part by the Federal Ministry of Education and Research (BMBF) Germany [01KH0402].</p><p id="__p7">The MCBCS was supported by the NIH grants [<a id="__tag_810965300" class="tag_hotlink" href="/nuccore/CA122340" ref="/nuccore/CA122340"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA122340","term_id":"34975648","term_text":"CA122340"}}</span>CA122340</a>, <a id="__tag_810965302" class="tag_hotlink" href="/nuccore/CA128978" ref="/nuccore/CA128978"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA128978","term_id":"35010393","term_text":"CA128978"}}</span>CA128978</a>] and a Specialized Program of Research Excellence (SPORE) in Breast Cancer [<a id="__tag_810965305" class="tag_hotlink" href="/nuccore/CA116201" ref="/nuccore/CA116201"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA116201","term_id":"34969508","term_text":"CA116201"}}</span>CA116201</a>].</p><p id="__p8">MCCS cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further supported by Australian NHMRC grants 209057, 251553 and 504711 and by infrastructure provided by Cancer Council Victoria.</p><p id="__p9">The Nurses’ Health Studies are supported by US NIH (National Institute of Health) grants CA65725, CA87969, CA49449, CA67262, CA50385 and 5UO1CA098233.</p><p id="__p10">OFBCR was supported by grant UM1 <a id="__tag_810965304" class="tag_hotlink" href="/nuccore/CA164920" ref="/nuccore/CA164920"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA164920","term_id":"35082813","term_text":"CA164920"}}</span>CA164920</a> from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the BCFR.</p><p id="__p11">The PBCS was funded by Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA.</p><p id="__p12">kConFab is supported by grants from the National Breast Cancer Foundation, the NHMRC, the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia and the Cancer Foundation of Western Australia. The kConFab Clinical Follow Up Study was funded by the NHMRC [145684, 288704, 454508]. Financial support for the AOCS was provided by the United States Army Medical Research and Materiel Command [DAMD17-01-1-0729], the Cancer Council of Tasmania and Cancer Foundation of Western Australia and the NHMRC [199600]. ABS is supported by an NHMRC Senior Research Fellowship.</p><p id="__p13">The Breakthrough Generations Study investigators thank Breakthrough Breast Cancer and the Institute of Cancer Research (ICR) for support and funding of the Breakthrough Generations Study. The ICR acknowledge NHS funding to the NIHR Biomedical Research Centre.</p><p id="__p14">This study would not have been possible without the contributions of the following: Per Hall (COGS); Douglas F. Easton, Paul Pharoah, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang (BCAC), Andrew Berchuck (OCAC), Rosalind A. Eeles, Douglas F. Easton, Ali Amin Al Olama, Zsofia Kote-Jarai, Sara Benlloch (PRACTICAL), Georgia Chenevix-Trench, Antonis Antoniou, Lesley McGuffog, Fergus Couch and Ken Offit (CIMBA), Joe Dennis, Alison M. Dunning, Andrew Lee, and Ed Dicks, Craig Luccarini and the staff of the Centre for Genetic Epidemiology Laboratory, Javier Benitez, Anna Gonzalez-Neira and the staff of the CNIO genotyping unit, Jacques Simard and Daniel C. Tessier, Francois Bacot, Daniel Vincent, Sylvie LaBoissière and Frederic Robidoux and the staff of the McGill University and Génome Québec Innovation Centre, Stig E. Bojesen, Sune F. Nielsen, Borge G. Nordestgaard, and the staff of the Copenhagen DNA laboratory, and Julie M. Cunningham, Sharon A. Windebank, Christopher A. Hilker, Jeffrey Meyer and the staff of Mayo Clinic Genotyping Core Facility</p><p id="__p15">We thank all the individuals who took part in these studies and all the researchers, clinicians, technicians and administrative staff who have enabled this work to be carried out. In particular, we thank: Ursula Eilber, Muhabbet Celik, Teresa Selander, Nayana Weerasooriya, Louise Brinton, Neonila Szeszenia-Dabrowska, Beata Peplonska, Witold Zatonski, Pei Chao, Michael Stagner, The GENICA network: Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and University of Tübingen, Germany [Wing-Yee Lo, HB]; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany [Yon-Dschun Ko, Christian Baisch]; Institute of Pathology, University of Bonn, Bonn, Germany [Hans-Peter Fischer]; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany [Ute Hamann]; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum, Germany [TB, Beate Pesch, Sylvia Rabstein, Anne Lotz] and Institute for Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Germany [VH], Heather Thorne, Eveline Niedermayr and the kConFab Clinical Follow-Up Study, the AOCS Management Group (D. Bowtell, G. Chenevix-Trench, A. deFazio, D. Gertig, A. Green, P. Webb), the ACS Management Group (A. Green, P. Parsons, N. Hayward, P. Webb, D. Whiteman); The Australian Cancer Study Management Group (A. Green, P. Parsons, N. Hayward, P.M.Webb, and D. Whiteman), project staff, collaborating institutions, clinical and scientific collaborators and study participants.</p></div></div><div id="idm140558572833488" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140558572833488title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"> </p><p id="__p16" class="p p-first"><strong>DECLARATION OF INTEREST</strong></p><p id="__p17" class="p p-last">The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.</p><p></p></div></div><div id="idm140558572822352" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140558572822352title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="R1"><span class="element-citation">Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. <span><span class="ref-journal">Menopause </span>2012</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3549049/">PMC free article</a>]</span> [<a href="/pubmed/23435034" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Menopause&amp;title=Breast+cancer+susceptibility+associated+with+rs1219648+(fibroblast+growth+factor+receptor+2)+and+postmenopausal+hormone+therapy+use+in+a+population-based+United+States+study&amp;author=SW+Andersen&amp;author=A+Trentham-Dietz&amp;author=JD+Figueroa&amp;author=LJ+Titus&amp;author=Q+Cai&amp;publication_year=2012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R2"><span class="element-citation">Aulchenko YS, Struchalin MV, van Duijn CM. ProbABEL package for genome-wide association analysis of imputed data. <span><span class="ref-journal">BMC Bioinformatics. </span>2010;<span class="ref-vol">11</span>:134.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2846909/">PMC free article</a>]</span> [<a href="/pubmed/20233392" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Bioinformatics&amp;title=ProbABEL+package+for+genome-wide+association+analysis+of+imputed+data&amp;author=YS+Aulchenko&amp;author=MV+Struchalin&amp;author=CM+van+Duijn&amp;volume=11&amp;publication_year=2010&amp;pages=134&amp;pmid=20233392&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R3"><span class="element-citation">Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, Fabre A, Hemon B, Rinaldi S, Chajes V, et al.  Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. <span><span class="ref-journal">Int J Cancer. </span>2011;<span class="ref-vol">128</span>:144–156.</span> [<a href="/pubmed/20232395" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=Menopausal+hormone+therapy+and+breast+cancer+risk:+impact+of+different+treatments.+The+European+Prospective+Investigation+into+Cancer+and+Nutrition&amp;author=K+Bakken&amp;author=A+Fournier&amp;author=E+Lund&amp;author=M+Waaseth&amp;author=V+Dumeaux&amp;volume=128&amp;publication_year=2011&amp;pages=144-156&amp;pmid=20232395&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R4"><span class="element-citation">Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. <span><span class="ref-journal">Bioinformatics. </span>2005;<span class="ref-vol">21</span>:263–265.</span> [<a href="/pubmed/15297300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Haploview:+analysis+and+visualization+of+LD+and+haplotype+maps&amp;author=JC+Barrett&amp;author=B+Fry&amp;author=J+Maller&amp;author=MJ+Daly&amp;volume=21&amp;publication_year=2005&amp;pages=263-265&amp;pmid=15297300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R5"><span class="element-citation">Bhatia S, Edidin M, Almo SC, Nathenson SG. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. <span><span class="ref-journal">Immunol Lett. </span>2006;<span class="ref-vol">104</span>:70–75.</span> [<a href="/pubmed/16413062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Lett&amp;title=B7-1+and+B7-2:+similar+costimulatory+ligands+with+different+biochemical,+oligomeric+and+signaling+properties&amp;author=S+Bhatia&amp;author=M+Edidin&amp;author=SC+Almo&amp;author=SG+Nathenson&amp;volume=104&amp;publication_year=2006&amp;pages=70-75&amp;pmid=16413062&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R6"><span class="element-citation">Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, Buring JE, Chanock SJ, Diver WR, Dostal L, et al.  Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. <span><span class="ref-journal">J Natl Cancer Inst. </span>2011;<span class="ref-vol">103</span>:1252–1263.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3156803/">PMC free article</a>]</span> [<a href="/pubmed/21791674" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Interactions+between+genetic+variants+and+breast+cancer+risk+factors+in+the+breast+and+prostate+cancer+cohort+consortium&amp;author=D+Campa&amp;author=R+Kaaks&amp;author=L+Le+Marchand&amp;author=CA+Haiman&amp;author=RC+Travis&amp;volume=103&amp;publication_year=2011&amp;pages=1252-1263&amp;pmid=21791674&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R7"><span class="element-citation">Chen B, Wilkening S, Drechsel M, Hemminki K. SNP_tools: A compact tool package for analysis and conversion of genotype data for MS-Excel. <span><span class="ref-journal">BMC Res Notes. </span>2009a;<span class="ref-vol">2</span>:214.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2771038/">PMC free article</a>]</span> [<a href="/pubmed/19852806" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Res+Notes&amp;title=SNP_tools:+A+compact+tool+package+for+analysis+and+conversion+of+genotype+data+for+MS-Excel&amp;author=B+Chen&amp;author=S+Wilkening&amp;author=M+Drechsel&amp;author=K+Hemminki&amp;volume=2&amp;publication_year=2009a&amp;pages=214&amp;pmid=19852806&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R8"><span class="element-citation">Chen JQ, Cammarata PR, Baines CP, Yager JD. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. <span><span class="ref-journal">Biochim Biophys Acta. </span>2009b;<span class="ref-vol">1793</span>:1540–1570.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2744640/">PMC free article</a>]</span> [<a href="/pubmed/19559056" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=Regulation+of+mitochondrial+respiratory+chain+biogenesis+by+estrogens/estrogen+receptors+and+physiological,+pathological+and+pharmacological+implications&amp;author=JQ+Chen&amp;author=PR+Cammarata&amp;author=CP+Baines&amp;author=JD+Yager&amp;volume=1793&amp;publication_year=2009b&amp;pages=1540-1570&amp;pmid=19559056&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R9"><span class="element-citation">Chlebowski RT, Anderson GL. Changing concepts: Menopausal hormone therapy and breast cancer. <span><span class="ref-journal">J Natl Cancer Inst. </span>2012;<span class="ref-vol">104</span>:517–527.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3317878/">PMC free article</a>]</span> [<a href="/pubmed/22427684" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Changing+concepts:+Menopausal+hormone+therapy+and+breast+cancer&amp;author=RT+Chlebowski&amp;author=GL+Anderson&amp;volume=104&amp;publication_year=2012&amp;pages=517-527&amp;pmid=22427684&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R10"><span class="element-citation">Dempfle A, Scherag A, Hein R, Beckmann L, Chang-Claude J, Schafer H. Gene-environment interactions for complex traits: definitions, methodological requirements and challenges. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:1164–1172.</span> [<a href="/pubmed/18523454" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Hum+Genet&amp;title=Gene-environment+interactions+for+complex+traits:+definitions,+methodological+requirements+and+challenges&amp;author=A+Dempfle&amp;author=A+Scherag&amp;author=R+Hein&amp;author=L+Beckmann&amp;author=J+Chang-Claude&amp;volume=16&amp;publication_year=2008&amp;pages=1164-1172&amp;pmid=18523454&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R11"><span class="element-citation">Farquhar C, Marjoribanks J, Lethaby A, Suckling JA, Lamberts Q. Long term hormone therapy for perimenopausal and postmenopausal women. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2009:CD004143.</span> [<a href="/pubmed/19370593" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane+Database+Syst+Rev&amp;title=Long+term+hormone+therapy+for+perimenopausal+and+postmenopausal+women&amp;author=C+Farquhar&amp;author=J+Marjoribanks&amp;author=A+Lethaby&amp;author=JA+Suckling&amp;author=Q+Lamberts&amp;publication_year=2009&amp;pages=CD004143&amp;pmid=19370593&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R12"><span class="element-citation">Fiermonte G, Dolce V, Palmieri L, Ventura M, Runswick MJ, Palmieri F, Walker JE. Identification of the human mitochondrial oxodicarboxylate carrier. Bacterial expression, reconstitution, functional characterization, tissue distribution, and chromosomal location. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:8225–8230.</span> [<a href="/pubmed/11083877" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Identification+of+the+human+mitochondrial+oxodicarboxylate+carrier.+Bacterial+expression,+reconstitution,+functional+characterization,+tissue+distribution,+and+chromosomal+location&amp;author=G+Fiermonte&amp;author=V+Dolce&amp;author=L+Palmieri&amp;author=M+Ventura&amp;author=MJ+Runswick&amp;volume=276&amp;publication_year=2001&amp;pages=8225-8230&amp;pmid=11083877&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R13"><span class="element-citation">Fischer C, Mazzone M, Jonckx B, Carmeliet P. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? <span><span class="ref-journal">Nat Rev Cancer. </span>2008;<span class="ref-vol">8</span>:942–956.</span> [<a href="/pubmed/19029957" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=FLT1+and+its+ligands+VEGFB+and+PlGF:+drug+targets+for+anti-angiogenic+therapy?&amp;author=C+Fischer&amp;author=M+Mazzone&amp;author=B+Jonckx&amp;author=P+Carmeliet&amp;volume=8&amp;publication_year=2008&amp;pages=942-956&amp;pmid=19029957&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R14"><span class="element-citation">Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Berger J, et al.  Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. <span><span class="ref-journal">Int J Cancer. </span>2008;<span class="ref-vol">123</span>:933–941.</span> [<a href="/pubmed/18506692" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=Risk+of+different+histological+types+of+postmenopausal+breast+cancer+by+type+and+regimen+of+menopausal+hormone+therapy&amp;author=D+Flesch-Janys&amp;author=T+Slanger&amp;author=E+Mutschelknauss&amp;author=S+Kropp&amp;author=N+Obi&amp;volume=123&amp;publication_year=2008&amp;pages=933-941&amp;pmid=18506692&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R15"><span class="element-citation">Garcia-Closas M, Rothman N, Lubin J. Misclassification in case-control studies of gene-environment interactions: assessment of bias and sample size. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>1999;<span class="ref-vol">8</span>:1043–1050.</span> [<a href="/pubmed/10613335" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Misclassification+in+case-control+studies+of+gene-environment+interactions:+assessment+of+bias+and+sample+size&amp;author=M+Garcia-Closas&amp;author=N+Rothman&amp;author=J+Lubin&amp;volume=8&amp;publication_year=1999&amp;pages=1043-1050&amp;pmid=10613335&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R16"><span class="element-citation">Gong J, Pan W, Yang C, Guo F, Sun Y. Expression of co-stimulators CD28/B7-1 in peripheral blood of patients with breast cancer. <span><span class="ref-journal">Breast Cancer Res Treat. </span>2012;<span class="ref-vol">136</span>:621–622.</span> [<a href="/pubmed/23053653" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=Expression+of+co-stimulators+CD28/B7-1+in+peripheral+blood+of+patients+with+breast+cancer&amp;author=J+Gong&amp;author=W+Pan&amp;author=C+Yang&amp;author=F+Guo&amp;author=Y+Sun&amp;volume=136&amp;publication_year=2012&amp;pages=621-622&amp;pmid=23053653&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R17"><span class="element-citation">Hein R, Abbas S, Seibold P, Salazar R, Flesch-Janys D, Chang-Claude J. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy. <span><span class="ref-journal">Breast Cancer Res Treat. </span>2012;<span class="ref-vol">131</span>:653–661.</span> [<a href="/pubmed/21947678" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=Polymorphism+Thr160Thr+in+SRD5A1,+involved+in+the+progesterone+metabolism,+modifies+postmenopausal+breast+cancer+risk+associated+with+menopausal+hormone+therapy&amp;author=R+Hein&amp;author=S+Abbas&amp;author=P+Seibold&amp;author=R+Salazar&amp;author=D+Flesch-Janys&amp;volume=131&amp;publication_year=2012&amp;pages=653-661&amp;pmid=21947678&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R18"><span class="element-citation">Hein R, Flesch-Janys D, Dahmen N, Beckmann L, Lindstrom S, Schoof N, Czene K, Mittelstrass K, Illig T, Seibold P, et al.  A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication. <span><span class="ref-journal">Breast Cancer Res Treat </span>2013</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3781176/">PMC free article</a>]</span> [<a href="/pubmed/23423446" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=A+genome-wide+association+study+to+identify+genetic+susceptibility+loci+that+modify+ductal+and+lobular+postmenopausal+breast+cancer+risk+associated+with+menopausal+hormone+therapy+use:+a+two-stage+design+with+replication&amp;author=R+Hein&amp;author=D+Flesch-Janys&amp;author=N+Dahmen&amp;author=L+Beckmann&amp;author=S+Lindstrom&amp;publication_year=2013&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R19"><span class="element-citation">Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. <span><span class="ref-journal">Stat Med. </span>2002;<span class="ref-vol">21</span>:1539–1558.</span> [<a href="/pubmed/12111919" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Stat+Med&amp;title=Quantifying+heterogeneity+in+a+meta-analysis&amp;author=JPT+Higgins&amp;author=SG+Thompson&amp;volume=21&amp;publication_year=2002&amp;pages=1539-1558&amp;pmid=12111919&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R20"><span class="element-citation">Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:870–874.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3493132/">PMC free article</a>]</span> [<a href="/pubmed/17529973" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+genome-wide+association+study+identifies+alleles+in+FGFR2+associated+with+risk+of+sporadic+postmenopausal+breast+cancer&amp;author=DJ+Hunter&amp;author=P+Kraft&amp;author=KB+Jacobs&amp;author=DG+Cox&amp;author=M+Yeager&amp;volume=39&amp;publication_year=2007&amp;pages=870-874&amp;pmid=17529973&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R21"><span class="element-citation">Justenhoven C, Obazee O, Brauch H. The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy. <span><span class="ref-journal">Pharmacogenomics. </span>2012;<span class="ref-vol">13</span>:659–675.</span> [<a href="/pubmed/22515609" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&amp;title=The+pharmacogenomics+of+sex+hormone+metabolism:+breast+cancer+risk+in+menopausal+hormone+therapy&amp;author=C+Justenhoven&amp;author=O+Obazee&amp;author=H+Brauch&amp;volume=13&amp;publication_year=2012&amp;pages=659-675&amp;pmid=22515609&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R22"><span class="element-citation">Kawase T, Matsuo K, Suzuki T, Hiraki A, Watanabe M, Iwata H, Tanaka H, Tajima K. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan. <span><span class="ref-journal">Int J Cancer. </span>2009;<span class="ref-vol">125</span>:1946–1952.</span> [<a href="/pubmed/19582883" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=FGFR2+intronic+polymorphisms+interact+with+reproductive+risk+factors+of+breast+cancer:+results+of+a+case+control+study+in+Japan&amp;author=T+Kawase&amp;author=K+Matsuo&amp;author=T+Suzuki&amp;author=A+Hiraki&amp;author=M+Watanabe&amp;volume=125&amp;publication_year=2009&amp;pages=1946-1952&amp;pmid=19582883&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R23"><span class="element-citation">Kilpivaara O, Vahteristo P, Falck J, Syrjakoski K, Eerola H, Easton D, Bartkova J, Lukas J, Heikkila P, Aittomaki K, et al.  CHEK2 variant I157T may be associated with increased breast cancer risk. <span><span class="ref-journal">Int J Cancer. </span>2004;<span class="ref-vol">111</span>:543–547.</span> [<a href="/pubmed/15239132" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=CHEK2+variant+I157T+may+be+associated+with+increased+breast+cancer+risk&amp;author=O+Kilpivaara&amp;author=P+Vahteristo&amp;author=J+Falck&amp;author=K+Syrjakoski&amp;author=H+Eerola&amp;volume=111&amp;publication_year=2004&amp;pages=543-547&amp;pmid=15239132&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R24"><span class="element-citation">Lee E, Schumacher F, Lewinger JP, Neuhausen SL, Anton-Culver H, Horn-Ross PL, Henderson KD, Ziogas A, Van Den Berg D, Bernstein L, et al.  The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort. <span><span class="ref-journal">Breast Cancer Res. </span>2011;<span class="ref-vol">13</span>:R37.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3219200/">PMC free article</a>]</span> [<a href="/pubmed/21457551" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res&amp;title=The+association+of+polymorphisms+in+hormone+metabolism+pathway+genes,+menopausal+hormone+therapy,+and+breast+cancer+risk:+a+nested+case-control+study+in+the+California+Teachers+Study+cohort&amp;author=E+Lee&amp;author=F+Schumacher&amp;author=JP+Lewinger&amp;author=SL+Neuhausen&amp;author=H+Anton-Culver&amp;volume=13&amp;publication_year=2011&amp;pages=R37&amp;pmid=21457551&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R25"><span class="element-citation">Li J, Humphreys K, Heikkinen T, Aittomaki K, Blomqvist C, Pharoah PD, Dunning AM, Ahmed S, Hooning MJ, Martens JW, et al.  A combined analysis of genome-wide association studies in breast cancer. <span><span class="ref-journal">Breast Cancer Res Treat. </span>2011;<span class="ref-vol">126</span>:717–727.</span> [<a href="/pubmed/20872241" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=A+combined+analysis+of+genome-wide+association+studies+in+breast+cancer&amp;author=J+Li&amp;author=K+Humphreys&amp;author=T+Heikkinen&amp;author=K+Aittomaki&amp;author=C+Blomqvist&amp;volume=126&amp;publication_year=2011&amp;pages=717-727&amp;pmid=20872241&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R26"><span class="element-citation">Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: Using Sequence and Genotype Data to Estimate Haplotypes and Unobserved Genotypes. <span><span class="ref-journal">Genet Epidemiol. </span>2010;<span class="ref-vol">34</span>:816–834.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3175618/">PMC free article</a>]</span> [<a href="/pubmed/21058334" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genet+Epidemiol&amp;title=MaCH:+Using+Sequence+and+Genotype+Data+to+Estimate+Haplotypes+and+Unobserved+Genotypes&amp;author=Y+Li&amp;author=CJ+Willer&amp;author=J+Ding&amp;author=P+Scheet&amp;author=GR+Abecasis&amp;volume=34&amp;publication_year=2010&amp;pages=816-834&amp;pmid=21058334&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R27"><span class="element-citation">Lin K, Taylor JR, Jr, Wu TD, Gutierrez J, Elliott JM, Vernes JM, Koeppen H, Phillips HS, de Sauvage FJ, Meng YG. TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma. <span><span class="ref-journal">PLoS One. </span>2011;<span class="ref-vol">6</span>:e18608.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3084709/">PMC free article</a>]</span> [<a href="/pubmed/21559523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=TMEFF2+is+a+PDGF-AA+binding+protein+with+methylation-associated+gene+silencing+in+multiple+cancer+types+including+glioma&amp;author=K+Lin&amp;author=JR+Taylor&amp;author=TD+Wu&amp;author=J+Gutierrez&amp;author=JM+Elliott&amp;volume=6&amp;publication_year=2011&amp;pages=e18608&amp;pmid=21559523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R28"><span class="element-citation">Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk. <span><span class="ref-journal">Nat Genet </span>2013</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3771688/">PMC free article</a>]</span> [<a href="/pubmed/23535729" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Large-scale+genotyping+identifies+41+new+loci+associated+with+breast+cancer+risk&amp;author=K+Michailidou&amp;author=P+Hall&amp;author=A+Gonzalez-Neira&amp;author=M+Ghoussaini&amp;author=J+Dennis&amp;publication_year=2013&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R29"><span class="element-citation">Morimoto LM, White E, Newcomb PA. Selection bias in the assessment of gene-environment interaction in case-control studies. <span><span class="ref-journal">Am J Epidemiol. </span>2003;<span class="ref-vol">158</span>:259–263.</span> [<a href="/pubmed/12882948" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol&amp;title=Selection+bias+in+the+assessment+of+gene-environment+interaction+in+case-control+studies&amp;author=LM+Morimoto&amp;author=E+White&amp;author=PA+Newcomb&amp;volume=158&amp;publication_year=2003&amp;pages=259-263&amp;pmid=12882948&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R30"><span class="element-citation">Narod SA. Hormone replacement therapy and the risk of breast cancer. <span><span class="ref-journal">Nat Rev Clin Oncol. </span>2011;<span class="ref-vol">8</span>:669–676.</span> [<a href="/pubmed/21808267" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Clin+Oncol&amp;title=Hormone+replacement+therapy+and+the+risk+of+breast+cancer&amp;author=SA+Narod&amp;volume=8&amp;publication_year=2011&amp;pages=669-676&amp;pmid=21808267&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R31"><span class="element-citation">Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Haberle L, Vrieling A, et al.  Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors. <span><span class="ref-journal">PLoS Genet. </span>2013;<span class="ref-vol">9</span>:e1003284.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3609648/">PMC free article</a>]</span> [<a href="/pubmed/23544014" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Evidence+of+Gene-Environment+Interactions+between+Common+Breast+Cancer+Susceptibility+Loci+and+Established+Environmental+Risk+Factors&amp;author=S+Nickels&amp;author=T+Truong&amp;author=R+Hein&amp;author=K+Stevens&amp;author=K+Buck&amp;volume=9&amp;publication_year=2013&amp;pages=e1003284&amp;pmid=23544014&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R32"><span class="element-citation">Park SY, Kwon HJ, Lee HE, Ryu HS, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH. Promoter CpG island hypermethylation during breast cancer progression. <span><span class="ref-journal">Virchows Arch. </span>2011;<span class="ref-vol">458</span>:73–84.</span> [<a href="/pubmed/21120523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virchows+Arch&amp;title=Promoter+CpG+island+hypermethylation+during+breast+cancer+progression&amp;author=SY+Park&amp;author=HJ+Kwon&amp;author=HE+Lee&amp;author=HS+Ryu&amp;author=SW+Kim&amp;volume=458&amp;publication_year=2011&amp;pages=73-84&amp;pmid=21120523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R33"><span class="element-citation">Piegorsch WW, Weinberg CR, Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. <span><span class="ref-journal">Stat Med. </span>1994;<span class="ref-vol">13</span>:153–162.</span> [<a href="/pubmed/8122051" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Stat+Med&amp;title=Non-hierarchical+logistic+models+and+case-only+designs+for+assessing+susceptibility+in+population-based+case-control+studies&amp;author=WW+Piegorsch&amp;author=CR+Weinberg&amp;author=JA+Taylor&amp;volume=13&amp;publication_year=1994&amp;pages=153-162&amp;pmid=8122051&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R34"><span class="element-citation">Prentice RL, Huang Y, Hinds DA, Peters U, Pettinger M, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, Caan B, et al.  Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2009;<span class="ref-vol">18</span>:3079–3085.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2783392/">PMC free article</a>]</span> [<a href="/pubmed/19861516" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Variation+in+the+FGFR2+gene+and+the+effects+of+postmenopausal+hormone+therapy+on+invasive+breast+cancer&amp;author=RL+Prentice&amp;author=Y+Huang&amp;author=DA+Hinds&amp;author=U+Peters&amp;author=M+Pettinger&amp;volume=18&amp;publication_year=2009&amp;pages=3079-3085&amp;pmid=19861516&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R35"><span class="element-citation">Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:559–575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;author=L+Thomas&amp;author=MA+Ferreira&amp;volume=81&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R36"><span class="element-citation">Rebbeck TR, DeMichele A, Tran TV, Panossian S, Bunin GR, Troxel AB, Strom BL. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. <span><span class="ref-journal">Carcinogenesis. </span>2009;<span class="ref-vol">30</span>:269–274.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2722148/">PMC free article</a>]</span> [<a href="/pubmed/19028704" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=Hormone-dependent+effects+of+FGFR2+and+MAP3K1+in+breast+cancer+susceptibility+in+a+population-based+sample+of+post-menopausal+African-American+and+European-American+women&amp;author=TR+Rebbeck&amp;author=A+DeMichele&amp;author=TV+Tran&amp;author=S+Panossian&amp;author=GR+Bunin&amp;volume=30&amp;publication_year=2009&amp;pages=269-274&amp;pmid=19028704&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R37"><span class="element-citation">Schwarzer G. <span><span class="ref-journal">meta: Meta-Analysis with R </span>2012</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=meta:+Meta-Analysis+with+R&amp;author=G+Schwarzer&amp;publication_year=2012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R38"><span class="element-citation">Shah NR, Borenstein J, Dubois RW. Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis. <span><span class="ref-journal">Menopause. </span>2005;<span class="ref-vol">12</span>:668–678.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1781058/">PMC free article</a>]</span> [<a href="/pubmed/16278609" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Menopause&amp;title=Postmenopausal+hormone+therapy+and+breast+cancer:+a+systematic+review+and+meta-analysis&amp;author=NR+Shah&amp;author=J+Borenstein&amp;author=RW+Dubois&amp;volume=12&amp;publication_year=2005&amp;pages=668-678&amp;pmid=16278609&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R39"><span class="element-citation">Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:2431–2442.</span> [<a href="/pubmed/12802030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Aromatase+inhibitors+in+breast+cancer&amp;author=IE+Smith&amp;author=M+Dowsett&amp;volume=348&amp;publication_year=2003&amp;pages=2431-2442&amp;pmid=12802030&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R40"><span class="element-citation">Sprague BL, Trentham-Dietz A, Cronin KA. A Sustained Decline in Postmenopausal Hormone Use Results From the National Health and Nutrition Examination Survey, 1999–2010. <span><span class="ref-journal">Obstet Gynecol. </span>2012;<span class="ref-vol">120</span>:595–603.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3607288/">PMC free article</a>]</span> [<a href="/pubmed/22914469" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Obstet+Gynecol&amp;title=A+Sustained+Decline+in+Postmenopausal+Hormone+Use+Results+From+the+National+Health+and+Nutrition+Examination+Survey,+1999–2010&amp;author=BL+Sprague&amp;author=A+Trentham-Dietz&amp;author=KA+Cronin&amp;volume=120&amp;publication_year=2012&amp;pages=595-603&amp;pmid=22914469&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R41"><span class="element-citation">Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. <span><span class="ref-journal">J Immunol. </span>2005;<span class="ref-vol">175</span>:749–754.</span> [<a href="/pubmed/16002670" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Phospholipase+C-gamma+2+is+a+critical+signaling+mediator+for+murine+NK+cell+activating+receptors&amp;author=I+Tassi&amp;author=R+Presti&amp;author=S+Kim&amp;author=WM+Yokoyama&amp;author=S+Gilfillan&amp;volume=175&amp;publication_year=2005&amp;pages=749-754&amp;pmid=16002670&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R42"><span class="element-citation">R Development Core Team. <span class="ref-journal">R: A Language and Environment for Statistical Computing.</span> Vienna, Austria: R Foundation for Statistical Computing; 2012.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=R:+A+Language+and+Environment+for+Statistical+Computing&amp;publication_year=2012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R43"><span class="element-citation">Travis RC, Reeves GK, Green J, Bull D, Tipper SJ, Baker K, Beral V, Peto R, Bell J, Zelenika D, et al.  Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. <span><span class="ref-journal">Lancet. </span>2010;<span class="ref-vol">375</span>:2143–2151.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2890858/">PMC free article</a>]</span> [<a href="/pubmed/20605201" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Gene-environment+interactions+in+7610+women+with+breast+cancer:+prospective+evidence+from+the+Million+Women+Study&amp;author=RC+Travis&amp;author=GK+Reeves&amp;author=J+Green&amp;author=D+Bull&amp;author=SJ+Tipper&amp;volume=375&amp;publication_year=2010&amp;pages=2143-2151&amp;pmid=20605201&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R44"><span class="element-citation">Tsai SA, Stefanick ML, Stafford RS. Trends in menopausal hormone therapy use of US office-based physicians, 2000–2009. <span><span class="ref-journal">Menopause. </span>2011;<span class="ref-vol">18</span>:385–392.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3123410/">PMC free article</a>]</span> [<a href="/pubmed/21127439" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Menopause&amp;title=Trends+in+menopausal+hormone+therapy+use+of+US+office-based+physicians,+2000–2009&amp;author=SA+Tsai&amp;author=ML+Stefanick&amp;author=RS+Stafford&amp;volume=18&amp;publication_year=2011&amp;pages=385-392&amp;pmid=21127439&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R45"><span class="element-citation">Wang D, Feng J, Wen R, Marine JC, Sangster MY, Parganas E, Hoffmeyer A, Jackson CW, Cleveland JL, Murray PJ, et al.  Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. <span><span class="ref-journal">Immunity. </span>2000;<span class="ref-vol">13</span>:25–35.</span> [<a href="/pubmed/10933392" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Phospholipase+Cgamma2+is+essential+in+the+functions+of+B+cell+and+several+Fc+receptors&amp;author=D+Wang&amp;author=J+Feng&amp;author=R+Wen&amp;author=JC+Marine&amp;author=MY+Sangster&amp;volume=13&amp;publication_year=2000&amp;pages=25-35&amp;pmid=10933392&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R46"><span class="element-citation">Wedren S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvanen AC, Kindmark A, Landegren U, Fermer ML, Stiger F, et al.  Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study. <span><span class="ref-journal">Breast Cancer Res. </span>2004;<span class="ref-vol">6</span>:R437–449.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC468663/">PMC free article</a>]</span> [<a href="/pubmed/15217512" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res&amp;title=Oestrogen+receptor+alpha+gene+haplotype+and+postmenopausal+breast+cancer+risk:+a+case+control+study&amp;author=S+Wedren&amp;author=L+Lovmar&amp;author=K+Humphreys&amp;author=C+Magnusson&amp;author=H+Melhus&amp;volume=6&amp;publication_year=2004&amp;pages=R437-449&amp;pmid=15217512&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="R47"><span class="element-citation">Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. <span><span class="ref-journal">Nat Rev Genet. </span>2004;<span class="ref-vol">5</span>:89–100.</span> [<a href="/pubmed/14735120" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=The+complex+interplay+among+factors+that+influence+allelic+association&amp;author=KT+Zondervan&amp;author=LR+Cardon&amp;volume=5&amp;publication_year=2004&amp;pages=89-100&amp;pmid=14735120&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3863710&amp;issue-id=231112&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li></ul></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140558573188192title">Abstract</a></li><li><a href="#S1title">INTRODUCTION</a></li><li><a href="#S2title">MATERIALS AND METHODS</a></li><li><a href="#S10title">RESULTS</a></li><li><a href="#S11title">DISCUSSION</a></li><li><a href="#S12title">Supplementary Material</a></li><li><a href="#S13title">Acknowledgments</a></li><li><a href="#idm140558572833488title">Footnotes</a></li><li><a href="#idm140558572822352title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3863710/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3863710/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3863710/pdf/nihms529599.pdf">PDF (505K)</a></li> | <li><a href="#" data-citationid="PMC3863710" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3863710%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3863710%2F&amp;text=Genetic%20modifiers%20of%20menopausal%20hormone%20replacement%20therapy%20and%20breast%20cancer%20risk%3A%20A%20genome-wide%20interaction%20study" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3863710%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="24080446" data-aiid="3863710" data-aid="3863710" data-iid="231112" data-domainid="319" data-domain="nihpa" data-accid="PMC3863710" data-md5="f91b9c7cad25dba35fd804ce8fcf9ea4"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T11:26:13-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal104&amp;ncbi_phid=CE8BB436DD561F210000000005D6035F&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3863710%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3863710/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>